<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"생물학적의약품" - Google 뉴스</title><link>https://news.google.com/search?pz=1&amp;cf=all&amp;hl=ko&amp;q=%EC%83%9D%EB%AC%BC%ED%95%99%EC%A0%81%EC%9D%98%EC%95%BD%ED%92%88&amp;cf=all&amp;gl=KR&amp;ceid=KR:ko</link><language>ko</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Sun, 14 Jun 2026 15:20:58 GMT</lastBuildDate><image><title>Google 뉴스</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google 뉴스</description><item><title>‘단백질의약품부터 세포치료제까지’ … 생물학적제제의 종류와 명명법 알아보기 - 헬스오</title><link>https://news.google.com/rss/articles/CBMidkFVX3lxTFBTMDEyekVuMVcta0Zhd3FxT1ZhTGFxWTIxN2haY0hSdzZocGpuaTg2OHVJN0VGd0VJbXp4YkNfN0V6V0U3VDlIclVJc3NsQl8wTGo5aFBHT3pTV2pIRTBzUVhHRHhmaURqR1lqNnN6VG56dzFfSHc?oc=5</link><guid isPermaLink="false">CBMidkFVX3lxTFBTMDEyekVuMVcta0Zhd3FxT1ZhTGFxWTIxN2haY0hSdzZocGpuaTg2OHVJN0VGd0VJbXp4YkNfN0V6V0U3VDlIclVJc3NsQl8wTGo5aFBHT3pTV2pIRTBzUVhHRHhmaURqR1lqNnN6VG56dzFfSHc</guid><pubDate>Thu, 11 Jun 2026 04:11:59 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBTMDEyekVuMVcta0Zhd3FxT1ZhTGFxWTIxN2haY0hSdzZocGpuaTg2OHVJN0VGd0VJbXp4YkNfN0V6V0U3VDlIclVJc3NsQl8wTGo5aFBHT3pTV2pIRTBzUVhHRHhmaURqR1lqNnN6VG56dzFfSHc?oc=5" target="_blank"&gt;‘단백질의약품부터 세포치료제까지’ … 생물학적제제의 종류와 명명법 알아보기&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스오&lt;/font&gt;</description><source url="https://healtho.co.kr">헬스오</source></item><item><title>'바이오시밀러 키우기’ 어디까지 왔나 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE56QWE2OUx4cVFZVlo3QkpQNjFNWi1OWEc5WUxxeHZnS3NzRXJFdXZXaHp6RzlzVGtVSGRNZTVxcmJ6Mng5RV81elZ6WG5RMEV3dW5mcDljc3gwakRsUk8xWjJMeGVzcjhKWFE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE56QWE2OUx4cVFZVlo3QkpQNjFNWi1OWEc5WUxxeHZnS3NzRXJFdXZXaHp6RzlzVGtVSGRNZTVxcmJ6Mng5RV81elZ6WG5RMEV3dW5mcDljc3gwakRsUk8xWjJMeGVzcjhKWFE</guid><pubDate>Thu, 21 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE56QWE2OUx4cVFZVlo3QkpQNjFNWi1OWEc5WUxxeHZnS3NzRXJFdXZXaHp6RzlzVGtVSGRNZTVxcmJ6Mng5RV81elZ6WG5RMEV3dW5mcDljc3gwakRsUk8xWjJMeGVzcjhKWFE?oc=5" target="_blank"&gt;'바이오시밀러 키우기’ 어디까지 왔나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>새로운 생물학적 제제가 농포성 건선 치료에 도움을 줍니다. - Vietnam.vn</title><link>https://news.google.com/rss/articles/CBMif0FVX3lxTE9sX0piQmdQY3RtbWg2SGJMOXo0WGRLVThkYTFjRWEyTWRKSDNRWEQxWERCLTVxOTNmVVFLRTNCVDF6Q1p2LU9sbGhnbHhUdWkxOWh0Vk1mbXM1ZndhNklNejFwZU5TSG1oTDV6M0FxNGhnZWhnRTY4VHdudlFBbGM?oc=5</link><guid isPermaLink="false">CBMif0FVX3lxTE9sX0piQmdQY3RtbWg2SGJMOXo0WGRLVThkYTFjRWEyTWRKSDNRWEQxWERCLTVxOTNmVVFLRTNCVDF6Q1p2LU9sbGhnbHhUdWkxOWh0Vk1mbXM1ZndhNklNejFwZU5TSG1oTDV6M0FxNGhnZWhnRTY4VHdudlFBbGM</guid><pubDate>Thu, 11 Jun 2026 01:09:02 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE9sX0piQmdQY3RtbWg2SGJMOXo0WGRLVThkYTFjRWEyTWRKSDNRWEQxWERCLTVxOTNmVVFLRTNCVDF6Q1p2LU9sbGhnbHhUdWkxOWh0Vk1mbXM1ZndhNklNejFwZU5TSG1oTDV6M0FxNGhnZWhnRTY4VHdudlFBbGM?oc=5" target="_blank"&gt;새로운 생물학적 제제가 농포성 건선 치료에 도움을 줍니다.&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Vietnam.vn&lt;/font&gt;</description><source url="https://www.vietnam.vn">Vietnam.vn</source></item><item><title>바이오시밀러 신속심사 길 열렸다…허가기간 단축 제도화 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE12V25PdHJzS3FlMEg5Z29LdUNiaGU2dGhYTmxjblVMVkpldFNob1VVVzdfWWgyeUN1MDk0d19FSzBTblVhX0N5Z2FhbVRKaXNpSE5LOGQxNVlfUmo1MVp0ekZaSnRhRHlMYk9F?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE12V25PdHJzS3FlMEg5Z29LdUNiaGU2dGhYTmxjblVMVkpldFNob1VVVzdfWWgyeUN1MDk0d19FSzBTblVhX0N5Z2FhbVRKaXNpSE5LOGQxNVlfUmo1MVp0ekZaSnRhRHlMYk9F</guid><pubDate>Mon, 06 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE12V25PdHJzS3FlMEg5Z29LdUNiaGU2dGhYTmxjblVMVkpldFNob1VVVzdfWWgyeUN1MDk0d19FSzBTblVhX0N5Z2FhbVRKaXNpSE5LOGQxNVlfUmo1MVp0ekZaSnRhRHlMYk9F?oc=5" target="_blank"&gt;바이오시밀러 신속심사 길 열렸다…허가기간 단축 제도화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>바이오시밀러 허가 빨라진다…식약처 신속심사 근거 마련 - 의협신문</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFBnaGdJU3BRdGpUaHUwQ2FlVVpYeVpoTEFnRWNyMDctdFJMTllZSnVGMWQ2OGZZTzJzYnExNUFUblladTNSTW9HbTVaUnJRVGRVT20xWWVqWXljRUhLcWdTMk82Mkp5SnJzUUEycEcwTXR6QQ?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFBnaGdJU3BRdGpUaHUwQ2FlVVpYeVpoTEFnRWNyMDctdFJMTllZSnVGMWQ2OGZZTzJzYnExNUFUblladTNSTW9HbTVaUnJRVGRVT20xWWVqWXljRUhLcWdTMk82Mkp5SnJzUUEycEcwTXR6QQ</guid><pubDate>Mon, 06 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBnaGdJU3BRdGpUaHUwQ2FlVVpYeVpoTEFnRWNyMDctdFJMTllZSnVGMWQ2OGZZTzJzYnExNUFUblladTNSTW9HbTVaUnJRVGRVT20xWWVqWXljRUhLcWdTMk82Mkp5SnJzUUEycEcwTXR6QQ?oc=5" target="_blank"&gt;바이오시밀러 허가 빨라진다…식약처 신속심사 근거 마련&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의협신문&lt;/font&gt;</description><source url="https://www.doctorsnews.co.kr">의협신문</source></item><item><title>바이오시밀러 허가 빨라진다…식약처, 행정지원 근거 마련 - 연합뉴스</title><link>https://news.google.com/rss/articles/CBMiW0FVX3lxTE15YXdDV09GdEpfeFBfYmFpRGNZdHBFZlhTOW1xMnk4dzVncEVBWEZqMS1sOXc3N3prSFpKdEZQZXFveU1DbXVvemNCdTdoNm1fTkIxT3ZlY3VOUFHSAWBBVV95cUxPTmJpdkdEQV9KSTZpMEM2aUEtbGN5N2UtR2lNVVB2OW9FX3loRm9jaHZibXhYQWpHUUZpcjA3SEhJZGRKXy1DdVpTMFZxek1vQlhUVm9VRTZ3UUw4TkdjN0Q?oc=5</link><guid isPermaLink="false">CBMiW0FVX3lxTE15YXdDV09GdEpfeFBfYmFpRGNZdHBFZlhTOW1xMnk4dzVncEVBWEZqMS1sOXc3N3prSFpKdEZQZXFveU1DbXVvemNCdTdoNm1fTkIxT3ZlY3VOUFHSAWBBVV95cUxPTmJpdkdEQV9KSTZpMEM2aUEtbGN5N2UtR2lNVVB2OW9FX3loRm9jaHZibXhYQWpHUUZpcjA3SEhJZGRKXy1DdVpTMFZxek1vQlhUVm9VRTZ3UUw4TkdjN0Q</guid><pubDate>Mon, 06 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE15YXdDV09GdEpfeFBfYmFpRGNZdHBFZlhTOW1xMnk4dzVncEVBWEZqMS1sOXc3N3prSFpKdEZQZXFveU1DbXVvemNCdTdoNm1fTkIxT3ZlY3VOUFHSAWBBVV95cUxPTmJpdkdEQV9KSTZpMEM2aUEtbGN5N2UtR2lNVVB2OW9FX3loRm9jaHZibXhYQWpHUUZpcjA3SEhJZGRKXy1DdVpTMFZxek1vQlhUVm9VRTZ3UUw4TkdjN0Q?oc=5" target="_blank"&gt;바이오시밀러 허가 빨라진다…식약처, 행정지원 근거 마련&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;연합뉴스&lt;/font&gt;</description><source url="https://www.yna.co.kr">연합뉴스</source></item><item><title>韓·美·EU "바이오시밀러 3상 건너뛴다"…삼성에피스·셀트리온 수혜 보나 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE5WN0JVOFB5ZkxNd1dZRzMyZUZDVVBpdF9POTY4cFcxektoQ3pUWDY3X3dhWUk5Y25ac21Bd1BWeEE5NEhKLVZ6aEk4RXBzSmJNWVFlZmdqNTZFQdIBVEFVX3lxTE5jZXF2UVNMeW54dDkwMVExUmJuRDQ5d3gzZTdtNGRtV0F1M1ViOW9UeEFKb1JqSVBfcVlwTFZRdVBtUXV4R3l2clQ4QVcxd1NFLWlnQw?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE5WN0JVOFB5ZkxNd1dZRzMyZUZDVVBpdF9POTY4cFcxektoQ3pUWDY3X3dhWUk5Y25ac21Bd1BWeEE5NEhKLVZ6aEk4RXBzSmJNWVFlZmdqNTZFQdIBVEFVX3lxTE5jZXF2UVNMeW54dDkwMVExUmJuRDQ5d3gzZTdtNGRtV0F1M1ViOW9UeEFKb1JqSVBfcVlwTFZRdVBtUXV4R3l2clQ4QVcxd1NFLWlnQw</guid><pubDate>Tue, 14 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5WN0JVOFB5ZkxNd1dZRzMyZUZDVVBpdF9POTY4cFcxektoQ3pUWDY3X3dhWUk5Y25ac21Bd1BWeEE5NEhKLVZ6aEk4RXBzSmJNWVFlZmdqNTZFQdIBVEFVX3lxTE5jZXF2UVNMeW54dDkwMVExUmJuRDQ5d3gzZTdtNGRtV0F1M1ViOW9UeEFKb1JqSVBfcVlwTFZRdVBtUXV4R3l2clQ4QVcxd1NFLWlnQw?oc=5" target="_blank"&gt;韓·美·EU "바이오시밀러 3상 건너뛴다"…삼성에피스·셀트리온 수혜 보나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>590兆 블록버스터 특허 풀린다…바이오시밀러 경쟁 본격화 - 조선비즈 - Chosunbiz</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxPUXd3VjZobE1ucy1MVjI4aUxMWm1YS245LWZiRU5Jd05rc2FnUVlpRlV5dXlBLWgtU3VOMl94ZHgzVnZ0RUFoaklnaEVhX0RyTlhBbW1kN0lsMFV3OUdTSUdrb2xUazF0b0FMcnI0YUpyQUNkR1p3Z2FTMlJueVh6Z29HYVJPbTDSAZsBQVVfeXFMTVF6UTZPOXdiRXk1ZTQ1R2xkeFRzeG15aGV6YWl2TF9DcVNJTlVjRU5WaHBQWnR4WUt5ME9Uelh4YnU3N0IyOURrQ1pGTG93bHJTTVpLcl9rN0VFU2tMUGVZcFZCcFNxX0piSGJWVDFTV2JKOVBjVkNuT3hMX1pYTENtVXJYT2ZIOU05dXpla2hqOVNndjlhU09NVkU?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxPUXd3VjZobE1ucy1MVjI4aUxMWm1YS245LWZiRU5Jd05rc2FnUVlpRlV5dXlBLWgtU3VOMl94ZHgzVnZ0RUFoaklnaEVhX0RyTlhBbW1kN0lsMFV3OUdTSUdrb2xUazF0b0FMcnI0YUpyQUNkR1p3Z2FTMlJueVh6Z29HYVJPbTDSAZsBQVVfeXFMTVF6UTZPOXdiRXk1ZTQ1R2xkeFRzeG15aGV6YWl2TF9DcVNJTlVjRU5WaHBQWnR4WUt5ME9Uelh4YnU3N0IyOURrQ1pGTG93bHJTTVpLcl9rN0VFU2tMUGVZcFZCcFNxX0piSGJWVDFTV2JKOVBjVkNuT3hMX1pYTENtVXJYT2ZIOU05dXpla2hqOVNndjlhU09NVkU</guid><pubDate>Fri, 13 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPUXd3VjZobE1ucy1MVjI4aUxMWm1YS245LWZiRU5Jd05rc2FnUVlpRlV5dXlBLWgtU3VOMl94ZHgzVnZ0RUFoaklnaEVhX0RyTlhBbW1kN0lsMFV3OUdTSUdrb2xUazF0b0FMcnI0YUpyQUNkR1p3Z2FTMlJueVh6Z29HYVJPbTDSAZsBQVVfeXFMTVF6UTZPOXdiRXk1ZTQ1R2xkeFRzeG15aGV6YWl2TF9DcVNJTlVjRU5WaHBQWnR4WUt5ME9Uelh4YnU3N0IyOURrQ1pGTG93bHJTTVpLcl9rN0VFU2tMUGVZcFZCcFNxX0piSGJWVDFTV2JKOVBjVkNuT3hMX1pYTENtVXJYT2ZIOU05dXpla2hqOVNndjlhU09NVkU?oc=5" target="_blank"&gt;590兆 블록버스터 특허 풀린다…바이오시밀러 경쟁 본격화 - 조선비즈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chosunbiz&lt;/font&gt;</description><source url="https://biz.chosun.com">Chosunbiz</source></item><item><title>FDA, 바이오시밀러 개발 간소화 지침 추가 공개 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE1EaVZOWG00QzlGdUw2VTYxdndELUVfanBMN3R0WTlUcHRBR0p2Q2xZRnhYYzBaSExwa1R1NU8zYzdwdFdFYVRLZHNEZ1V2dEJvU1NMVkprVGJsYXBaODdfUjVWclJ5dw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE1EaVZOWG00QzlGdUw2VTYxdndELUVfanBMN3R0WTlUcHRBR0p2Q2xZRnhYYzBaSExwa1R1NU8zYzdwdFdFYVRLZHNEZ1V2dEJvU1NMVkprVGJsYXBaODdfUjVWclJ5dw</guid><pubDate>Tue, 10 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE1EaVZOWG00QzlGdUw2VTYxdndELUVfanBMN3R0WTlUcHRBR0p2Q2xZRnhYYzBaSExwa1R1NU8zYzdwdFdFYVRLZHNEZ1V2dEJvU1NMVkprVGJsYXBaODdfUjVWclJ5dw?oc=5" target="_blank"&gt;FDA, 바이오시밀러 개발 간소화 지침 추가 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>식약처, 신속심사 대상에 '바이오시밀러' 추가…근거규정 마련 - 뉴스1</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTE1nOGdtWWhVN0k0OEpjOEpEWU1aOXpaZFVBSVBpRS1XNVRVdk1DX3QzUExDQ1ZfMVY1Ny13cm5ST3B2SE1tT0J3Uzc0dFF0REl2ekQ2YzRMSjJKSWUtb0sxMg?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTE1nOGdtWWhVN0k0OEpjOEpEWU1aOXpaZFVBSVBpRS1XNVRVdk1DX3QzUExDQ1ZfMVY1Ny13cm5ST3B2SE1tT0J3Uzc0dFF0REl2ekQ2YzRMSjJKSWUtb0sxMg</guid><pubDate>Mon, 06 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1nOGdtWWhVN0k0OEpjOEpEWU1aOXpaZFVBSVBpRS1XNVRVdk1DX3QzUExDQ1ZfMVY1Ny13cm5ST3B2SE1tT0J3Uzc0dFF0REl2ekQ2YzRMSjJKSWUtb0sxMg?oc=5" target="_blank"&gt;식약처, 신속심사 대상에 '바이오시밀러' 추가…근거규정 마련&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스1&lt;/font&gt;</description><source url="https://www.news1.kr">뉴스1</source></item><item><title>바이오시밀러, 신속하게 심사 받는다 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE1yTGNUejRNLTgzUHpQVFNjTUNxTS1Qcm5RZjlud1N6YnZhWDc2clRWbFZZbEtzeTV2bV9QanZPazB1UWNCZXVPMkNxLUhnV0FoSFNKYUIzVTNnQ1dSNUlRZWlBWVoxMUQ3ZHc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE1yTGNUejRNLTgzUHpQVFNjTUNxTS1Qcm5RZjlud1N6YnZhWDc2clRWbFZZbEtzeTV2bV9QanZPazB1UWNCZXVPMkNxLUhnV0FoSFNKYUIzVTNnQ1dSNUlRZWlBWVoxMUQ3ZHc</guid><pubDate>Mon, 06 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1yTGNUejRNLTgzUHpQVFNjTUNxTS1Qcm5RZjlud1N6YnZhWDc2clRWbFZZbEtzeTV2bV9QanZPazB1UWNCZXVPMkNxLUhnV0FoSFNKYUIzVTNnQ1dSNUlRZWlBWVoxMUQ3ZHc?oc=5" target="_blank"&gt;바이오시밀러, 신속하게 심사 받는다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>알보테크, 세계 첫 심포니 바이오시밀러 유럽 출시..NHS 입찰 수주 - 매일경제 마켓</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTE9oeS1RcHdnMXJXazBMRTc5aktFTEdxWTFMQkZoRjl3VGNhZHgxZzhkMFVBNUZPQjB5blBabzMtdnVNVnBCanJNUjdoc2M3Q3lk?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTE9oeS1RcHdnMXJXazBMRTc5aktFTEdxWTFMQkZoRjl3VGNhZHgxZzhkMFVBNUZPQjB5blBabzMtdnVNVnBCanJNUjdoc2M3Q3lk</guid><pubDate>Wed, 24 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9oeS1RcHdnMXJXazBMRTc5aktFTEdxWTFMQkZoRjl3VGNhZHgxZzhkMFVBNUZPQjB5blBabzMtdnVNVnBCanJNUjdoc2M3Q3lk?oc=5" target="_blank"&gt;알보테크, 세계 첫 심포니 바이오시밀러 유럽 출시..NHS 입찰 수주&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;매일경제 마켓&lt;/font&gt;</description><source url="https://stock.mk.co.kr">매일경제 마켓</source></item><item><title>美 정책에 희비교차...바이오시밀러 업계는 화색[클릭, 글로벌 제약·바이오] - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE10ZzJNcUZnNV9rRDlTVC1mV1puek1jcEl5MGYtOWpPVGxaY2JWTjB6NThLVXlldndUVXduRmc1alJuTnVfbU5laUx3NXZWNGNScjhONXJBVDFtMVlqN05uZFBjZVNpelp2UFpLcTBB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE10ZzJNcUZnNV9rRDlTVC1mV1puek1jcEl5MGYtOWpPVGxaY2JWTjB6NThLVXlldndUVXduRmc1alJuTnVfbU5laUx3NXZWNGNScjhONXJBVDFtMVlqN05uZFBjZVNpelp2UFpLcTBB</guid><pubDate>Sun, 02 Nov 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE10ZzJNcUZnNV9rRDlTVC1mV1puek1jcEl5MGYtOWpPVGxaY2JWTjB6NThLVXlldndUVXduRmc1alJuTnVfbU5laUx3NXZWNGNScjhONXJBVDFtMVlqN05uZFBjZVNpelp2UFpLcTBB?oc=5" target="_blank"&gt;美 정책에 희비교차...바이오시밀러 업계는 화색[클릭, 글로벌 제약·바이오]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>K-바이오시밀러 10년…올해 美 FDA 허가 '최다' - 서울경제TV</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTFBUc1M1RVRxNy02cjdXUFBKQlpxbDJrdVRwbzhnRkU1N3VsdFppQTVydGRWYWhQelI3cVhHRlFYeUpuS0dIZFBtb1Q2V3hFX1pDVU42SURhcUR1cHJiSEFldmZXY3I?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTFBUc1M1RVRxNy02cjdXUFBKQlpxbDJrdVRwbzhnRkU1N3VsdFppQTVydGRWYWhQelI3cVhHRlFYeUpuS0dIZFBtb1Q2V3hFX1pDVU42SURhcUR1cHJiSEFldmZXY3I</guid><pubDate>Fri, 10 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFBUc1M1RVRxNy02cjdXUFBKQlpxbDJrdVRwbzhnRkU1N3VsdFppQTVydGRWYWhQelI3cVhHRlFYeUpuS0dIZFBtb1Q2V3hFX1pDVU42SURhcUR1cHJiSEFldmZXY3I?oc=5" target="_blank"&gt;K-바이오시밀러 10년…올해 美 FDA 허가 '최다'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제TV&lt;/font&gt;</description><source url="https://www.sentv.co.kr">서울경제TV</source></item><item><title>바이오시밀러·항체의약품 등 시장 성장 견인 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9yUnVJMTJuLWFmdkxvTDU5dlVfR2RnczYxeDVQZVlLXzB4eVBSNDU3VjlWWmg1LVJEWnNuMkFwbzZZOW9ZbUo2bEN6MzM2d1BSRVZKMW9Ub1VsWENWTFZlNUI4enJqdkJYWkE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9yUnVJMTJuLWFmdkxvTDU5dlVfR2RnczYxeDVQZVlLXzB4eVBSNDU3VjlWWmg1LVJEWnNuMkFwbzZZOW9ZbUo2bEN6MzM2d1BSRVZKMW9Ub1VsWENWTFZlNUI4enJqdkJYWkE</guid><pubDate>Mon, 29 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9yUnVJMTJuLWFmdkxvTDU5dlVfR2RnczYxeDVQZVlLXzB4eVBSNDU3VjlWWmg1LVJEWnNuMkFwbzZZOW9ZbUo2bEN6MzM2d1BSRVZKMW9Ub1VsWENWTFZlNUI4enJqdkJYWkE?oc=5" target="_blank"&gt;바이오시밀러·항체의약품 등 시장 성장 견인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>美 FDA, 바이오시밀러 규제 완화…약가 인하·접근성 확대 기대 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE90eUNLamlVNEVzSURNMWZWcldtTzhSblZmQno1a1VCaE1fTmlmSUxhcXJZQUdGZ0JfMGRpNnJCUURxZk9vblNvdTlLS0lmdmJwVlBwZFE1NTJEdnlpREt4Tk5sa2dnOXpudUthMnljTdIBc0FVX3lxTE9iaVU5WV9fWUZuNVpTU2ZhMDZPcnJrZy1maExxVUN6ZjV0Z295Ti1zVWhjbTh5b0hIQzZZTEF6U3JrcnM4S1diZ0p5ZE92NVJZNENiakdFX09hOWc4Zk1Tanh6STRzcjVqcDFUOGt2ZW9abUk?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE90eUNLamlVNEVzSURNMWZWcldtTzhSblZmQno1a1VCaE1fTmlmSUxhcXJZQUdGZ0JfMGRpNnJCUURxZk9vblNvdTlLS0lmdmJwVlBwZFE1NTJEdnlpREt4Tk5sa2dnOXpudUthMnljTdIBc0FVX3lxTE9iaVU5WV9fWUZuNVpTU2ZhMDZPcnJrZy1maExxVUN6ZjV0Z295Ti1zVWhjbTh5b0hIQzZZTEF6U3JrcnM4S1diZ0p5ZE92NVJZNENiakdFX09hOWc4Zk1Tanh6STRzcjVqcDFUOGt2ZW9abUk</guid><pubDate>Mon, 03 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE90eUNLamlVNEVzSURNMWZWcldtTzhSblZmQno1a1VCaE1fTmlmSUxhcXJZQUdGZ0JfMGRpNnJCUURxZk9vblNvdTlLS0lmdmJwVlBwZFE1NTJEdnlpREt4Tk5sa2dnOXpudUthMnljTdIBc0FVX3lxTE9iaVU5WV9fWUZuNVpTU2ZhMDZPcnJrZy1maExxVUN6ZjV0Z295Ti1zVWhjbTh5b0hIQzZZTEF6U3JrcnM4S1diZ0p5ZE92NVJZNENiakdFX09hOWc4Zk1Tanh6STRzcjVqcDFUOGt2ZW9abUk?oc=5" target="_blank"&gt;美 FDA, 바이오시밀러 규제 완화…약가 인하·접근성 확대 기대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>K-바이오 호재일까…FDA, 시밀러 진입 장벽 완화 추진 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiTEFVX3lxTE1vbXBDaEtYdWZzaHRtODlpaUtnTUF6Skw3WHJzRHFUdWJyUWVMZ1ZYOGN4ZVRxd3VfdnVXWW1qX1hWTl9ENkk5WlhuV2Y?oc=5</link><guid isPermaLink="false">CBMiTEFVX3lxTE1vbXBDaEtYdWZzaHRtODlpaUtnTUF6Skw3WHJzRHFUdWJyUWVMZ1ZYOGN4ZVRxd3VfdnVXWW1qX1hWTl9ENkk5WlhuV2Y</guid><pubDate>Fri, 31 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiTEFVX3lxTE1vbXBDaEtYdWZzaHRtODlpaUtnTUF6Skw3WHJzRHFUdWJyUWVMZ1ZYOGN4ZVRxd3VfdnVXWW1qX1hWTl9ENkk5WlhuV2Y?oc=5" target="_blank"&gt;K-바이오 호재일까…FDA, 시밀러 진입 장벽 완화 추진&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>미 FDA, 바이오시밀러 승인 절차 간소화 - 연합뉴스</title><link>https://news.google.com/rss/articles/CBMiW0FVX3lxTE5tMWIyMnpPMzlRcXdnRGp2OGplWE8xYmR3RDRfemZZQ2hfRFotUGN0VGZVYWltRWZIbkhNdnBsZUtEcXFLU0ppN3pYdU5BRExGOXZUYVRMckRCcW_SAWBBVV95cUxPT2huZ0pKZm95YXFCUTlkMEwzT3kyemx6QjNNRVpOSXNpVFYtUUNPWDlnWjNEY1kyTW0tYlFvN2tKN2JjdEhtRzYzaDhfSktKaGVuZ25xVUNNdUthckExalU?oc=5</link><guid isPermaLink="false">CBMiW0FVX3lxTE5tMWIyMnpPMzlRcXdnRGp2OGplWE8xYmR3RDRfemZZQ2hfRFotUGN0VGZVYWltRWZIbkhNdnBsZUtEcXFLU0ppN3pYdU5BRExGOXZUYVRMckRCcW_SAWBBVV95cUxPT2huZ0pKZm95YXFCUTlkMEwzT3kyemx6QjNNRVpOSXNpVFYtUUNPWDlnWjNEY1kyTW0tYlFvN2tKN2JjdEhtRzYzaDhfSktKaGVuZ25xVUNNdUthckExalU</guid><pubDate>Thu, 30 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE5tMWIyMnpPMzlRcXdnRGp2OGplWE8xYmR3RDRfemZZQ2hfRFotUGN0VGZVYWltRWZIbkhNdnBsZUtEcXFLU0ppN3pYdU5BRExGOXZUYVRMckRCcW_SAWBBVV95cUxPT2huZ0pKZm95YXFCUTlkMEwzT3kyemx6QjNNRVpOSXNpVFYtUUNPWDlnWjNEY1kyTW0tYlFvN2tKN2JjdEhtRzYzaDhfSktKaGVuZ25xVUNNdUthckExalU?oc=5" target="_blank"&gt;미 FDA, 바이오시밀러 승인 절차 간소화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;연합뉴스&lt;/font&gt;</description><source url="https://www.yna.co.kr">연합뉴스</source></item><item><title>FDA, 바이오시밀러 개발ㆍ약가인하 가속화 행보 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTFBKdEt3RUxqYkdnc0JyUTBnRXRZdExZRlFKeXFpb2lhaGhPNFZ4MUF2dVM0TUpHNUpFUTQ1cGVZVFRoNFJ4SlRhNjBobURSS3oyQkg2YzU3VEkyQ203bzNMa3A0VWQ0UQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTFBKdEt3RUxqYkdnc0JyUTBnRXRZdExZRlFKeXFpb2lhaGhPNFZ4MUF2dVM0TUpHNUpFUTQ1cGVZVFRoNFJ4SlRhNjBobURSS3oyQkg2YzU3VEkyQ203bzNMa3A0VWQ0UQ</guid><pubDate>Fri, 31 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFBKdEt3RUxqYkdnc0JyUTBnRXRZdExZRlFKeXFpb2lhaGhPNFZ4MUF2dVM0TUpHNUpFUTQ1cGVZVFRoNFJ4SlRhNjBobURSS3oyQkg2YzU3VEkyQ203bzNMa3A0VWQ0UQ?oc=5" target="_blank"&gt;FDA, 바이오시밀러 개발ㆍ약가인하 가속화 행보&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>바이오시밀러 개발 문턱 낮추는 FDA[제약·바이오 해외토픽] - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE51SlRmVGFiaTdLdHI0S1o3Z2MzdTkyOTRqZnRHNll1YlJxNDhpRW45ZXVEa2pibmw3aGxhcGtPNlRJYzVzeVAtM0ljZ0pRbFRoT1BlTFVrUUQ4OU94ZnNPNHRPcFhrQjdzeVRLMU53?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE51SlRmVGFiaTdLdHI0S1o3Z2MzdTkyOTRqZnRHNll1YlJxNDhpRW45ZXVEa2pibmw3aGxhcGtPNlRJYzVzeVAtM0ljZ0pRbFRoT1BlTFVrUUQ4OU94ZnNPNHRPcFhrQjdzeVRLMU53</guid><pubDate>Sat, 01 Nov 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE51SlRmVGFiaTdLdHI0S1o3Z2MzdTkyOTRqZnRHNll1YlJxNDhpRW45ZXVEa2pibmw3aGxhcGtPNlRJYzVzeVAtM0ljZ0pRbFRoT1BlTFVrUUQ4OU94ZnNPNHRPcFhrQjdzeVRLMU53?oc=5" target="_blank"&gt;바이오시밀러 개발 문턱 낮추는 FDA[제약·바이오 해외토픽]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>허가심사료 3억원 예고한 식약처 "바이오시밀러 전담팀 구축" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1MYWhDSThaRnllX0ZaOF80UkFOUzhfdmQ1YU9NLVV1cHNkbWJxUTUwdm1XZS1PYWJqWHpDdTVISUEtNm9BS2tpM0cycnhGSkhHOVc2VmhSWUEtb1pZUl9qV2ZYN2lRNlZwaWxR?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1MYWhDSThaRnllX0ZaOF80UkFOUzhfdmQ1YU9NLVV1cHNkbWJxUTUwdm1XZS1PYWJqWHpDdTVISUEtNm9BS2tpM0cycnhGSkhHOVc2VmhSWUEtb1pZUl9qV2ZYN2lRNlZwaWxR</guid><pubDate>Wed, 17 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1MYWhDSThaRnllX0ZaOF80UkFOUzhfdmQ1YU9NLVV1cHNkbWJxUTUwdm1XZS1PYWJqWHpDdTVISUEtNm9BS2tpM0cycnhGSkhHOVc2VmhSWUEtb1pZUl9qV2ZYN2lRNlZwaWxR?oc=5" target="_blank"&gt;허가심사료 3억원 예고한 식약처 "바이오시밀러 전담팀 구축"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>COPD 치료도 ‘듀피젠트’…“최초의 생물학적 의약품” - 메디포뉴스</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE5jaDhsM2dDTldXNDRhckhEenVNVXh6TEdrR3pxc1NWM3FZeEdMbE9vZks4SHd0VGNjOTdGazhHQWhZQkNaLWxHdzFZRDhNWDRrV1FyQ0VCOEktbkdKWGxXRVc0THM?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE5jaDhsM2dDTldXNDRhckhEenVNVXh6TEdrR3pxc1NWM3FZeEdMbE9vZks4SHd0VGNjOTdGazhHQWhZQkNaLWxHdzFZRDhNWDRrV1FyQ0VCOEktbkdKWGxXRVc0THM</guid><pubDate>Thu, 10 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE5jaDhsM2dDTldXNDRhckhEenVNVXh6TEdrR3pxc1NWM3FZeEdMbE9vZks4SHd0VGNjOTdGazhHQWhZQkNaLWxHdzFZRDhNWDRrV1FyQ0VCOEktbkdKWGxXRVc0THM?oc=5" target="_blank"&gt;COPD 치료도 ‘듀피젠트’…“최초의 생물학적 의약품”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디포뉴스&lt;/font&gt;</description><source url="https://www.medifonews.com">메디포뉴스</source></item><item><title>"240일로 당긴다"…식약처, 바이오시밀러 심사체계 개편 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9jdVlSbGVJNjhRZk96MGFrNmRCZDBUZHdHY1J1bUZYVkJUN3VTRWVoTGw0UHRUbTVnYU5xakRRSHhTbHNhaDlPcENaYVZXM2VFWHFnRV92amFqY1lzQUE0ZEpUNFpBXzVpQUpZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9jdVlSbGVJNjhRZk96MGFrNmRCZDBUZHdHY1J1bUZYVkJUN3VTRWVoTGw0UHRUbTVnYU5xakRRSHhTbHNhaDlPcENaYVZXM2VFWHFnRV92amFqY1lzQUE0ZEpUNFpBXzVpQUpZ</guid><pubDate>Mon, 23 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9jdVlSbGVJNjhRZk96MGFrNmRCZDBUZHdHY1J1bUZYVkJUN3VTRWVoTGw0UHRUbTVnYU5xakRRSHhTbHNhaDlPcENaYVZXM2VFWHFnRV92amFqY1lzQUE0ZEpUNFpBXzVpQUpZ?oc=5" target="_blank"&gt;"240일로 당긴다"…식약처, 바이오시밀러 심사체계 개편&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>바이오시밀러 ‘3상 면제’ 길 열린다…“비교동등성 입증 전제 간소화” - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1jME5zclpHSmktazlEN0dOWDBjSHRMRHR3YXMzaEo5Q2hiall3TXhJLWlmcF84U1pkSTRsRXI2eEowWWxzZk9hNmhpYko0eGZEZUZjd2lWLVBvNTlmY3pCOEFwT1lJZU1hN0tyLQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1jME5zclpHSmktazlEN0dOWDBjSHRMRHR3YXMzaEo5Q2hiall3TXhJLWlmcF84U1pkSTRsRXI2eEowWWxzZk9hNmhpYko0eGZEZUZjd2lWLVBvNTlmY3pCOEFwT1lJZU1hN0tyLQ</guid><pubDate>Fri, 29 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1jME5zclpHSmktazlEN0dOWDBjSHRMRHR3YXMzaEo5Q2hiall3TXhJLWlmcF84U1pkSTRsRXI2eEowWWxzZk9hNmhpYko0eGZEZUZjd2lWLVBvNTlmY3pCOEFwT1lJZU1hN0tyLQ?oc=5" target="_blank"&gt;바이오시밀러 ‘3상 면제’ 길 열린다…“비교동등성 입증 전제 간소화”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>日, 바이오시밀러 처방 의사에 정부 보조금…한국은 인센티브 '0' - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE9VSldDbno5ZHpDb0NoWWx1QnhDWGx1RzhsakdmZ1lhSXI2R2JFcEJ3ZC0wVUVaWkVjcThqRVItb0pWZHcwNndqb3E4Z19mMU5lSkd6bl9QdS00d9IBVEFVX3lxTFBrS2FINWtMRjI2aUtoNVl1Ymd2c1NQS1o5bzZlWURZOFRrbS00X0theWkxNm9mbmpmbXhXWGZZTlBiODNKSHpfWGc4ZWludGNEdTJnNQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE9VSldDbno5ZHpDb0NoWWx1QnhDWGx1RzhsakdmZ1lhSXI2R2JFcEJ3ZC0wVUVaWkVjcThqRVItb0pWZHcwNndqb3E4Z19mMU5lSkd6bl9QdS00d9IBVEFVX3lxTFBrS2FINWtMRjI2aUtoNVl1Ymd2c1NQS1o5bzZlWURZOFRrbS00X0theWkxNm9mbmpmbXhXWGZZTlBiODNKSHpfWGc4ZWludGNEdTJnNQ</guid><pubDate>Fri, 10 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE9VSldDbno5ZHpDb0NoWWx1QnhDWGx1RzhsakdmZ1lhSXI2R2JFcEJ3ZC0wVUVaWkVjcThqRVItb0pWZHcwNndqb3E4Z19mMU5lSkd6bl9QdS00d9IBVEFVX3lxTFBrS2FINWtMRjI2aUtoNVl1Ymd2c1NQS1o5bzZlWURZOFRrbS00X0theWkxNm9mbmpmbXhXWGZZTlBiODNKSHpfWGc4ZWludGNEdTJnNQ?oc=5" target="_blank"&gt;日, 바이오시밀러 처방 의사에 정부 보조금…한국은 인센티브 '0'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>글로벌 바이오시밀러 규제 완화 본격화…"셀트리온·삼성바이오에피스 수혜 기대" - 디일렉</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE53ZUFLR0lRcmVTX1liZ3dqOFEzSmhHQ1RBOFBZdnRfUHYwS3hIRXpsdU1QdUZNX2ZxWmR4MURNV2xrdkhIa3U0UXFMTy1OX3dKRlRJX0QtUlBPTVhvUG1SNGd4dGpHdw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE53ZUFLR0lRcmVTX1liZ3dqOFEzSmhHQ1RBOFBZdnRfUHYwS3hIRXpsdU1QdUZNX2ZxWmR4MURNV2xrdkhIa3U0UXFMTy1OX3dKRlRJX0QtUlBPTVhvUG1SNGd4dGpHdw</guid><pubDate>Mon, 01 Jun 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE53ZUFLR0lRcmVTX1liZ3dqOFEzSmhHQ1RBOFBZdnRfUHYwS3hIRXpsdU1QdUZNX2ZxWmR4MURNV2xrdkhIa3U0UXFMTy1OX3dKRlRJX0QtUlBPTVhvUG1SNGd4dGpHdw?oc=5" target="_blank"&gt;글로벌 바이오시밀러 규제 완화 본격화…"셀트리온·삼성바이오에피스 수혜 기대"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;디일렉&lt;/font&gt;</description><source url="https://www.thelec.kr">디일렉</source></item><item><title>한국산 의약품, 미국 관세 15% 적용…바이오시밀러는 1년간 무관세 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBLVEFQejJJMktCVTJwemx5allLVFZQbHB0ZWtobk53Y0FldE9DbDNGSUdPSEZRc0FEYVptUHZkWHY5R2dGcHhtNk9TT19ubU1maEU5RVQ2enRMSHFOM3VPaThEc1RpZHZtakxIQkR3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBLVEFQejJJMktCVTJwemx5allLVFZQbHB0ZWtobk53Y0FldE9DbDNGSUdPSEZRc0FEYVptUHZkWHY5R2dGcHhtNk9TT19ubU1maEU5RVQ2enRMSHFOM3VPaThEc1RpZHZtakxIQkR3</guid><pubDate>Fri, 03 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBLVEFQejJJMktCVTJwemx5allLVFZQbHB0ZWtobk53Y0FldE9DbDNGSUdPSEZRc0FEYVptUHZkWHY5R2dGcHhtNk9TT19ubU1maEU5RVQ2enRMSHFOM3VPaThEc1RpZHZtakxIQkR3?oc=5" target="_blank"&gt;한국산 의약품, 미국 관세 15% 적용…바이오시밀러는 1년간 무관세&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>공급 부족 바이오의약품, 신속 심사로 빠르게 제공한다 - 연합뉴스</title><link>https://news.google.com/rss/articles/CBMiW0FVX3lxTE5zZGJ6VFAyRTJwTzRWOTY2OUVBSmg3N01EV0Y2eUQxWFI3WmR2VWNUUzJJMVFGRktlZ1pUbS16Nk5JbWJRQWU3UExTTTliOUhXU01xN2pOREhOTDTSAWBBVV95cUxOSUtGRlZJTWRmXzctaEUyZG1CYlMxTTBSell2NnFyS2pzNzhNelQzbVRUMndfQ1RGdmRBSzRrenlJcjRkaWRPT1dPY0F5WmhIMFRweTB3NXFGZWRQSDBYVGo?oc=5</link><guid isPermaLink="false">CBMiW0FVX3lxTE5zZGJ6VFAyRTJwTzRWOTY2OUVBSmg3N01EV0Y2eUQxWFI3WmR2VWNUUzJJMVFGRktlZ1pUbS16Nk5JbWJRQWU3UExTTTliOUhXU01xN2pOREhOTDTSAWBBVV95cUxOSUtGRlZJTWRmXzctaEUyZG1CYlMxTTBSell2NnFyS2pzNzhNelQzbVRUMndfQ1RGdmRBSzRrenlJcjRkaWRPT1dPY0F5WmhIMFRweTB3NXFGZWRQSDBYVGo</guid><pubDate>Wed, 12 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE5zZGJ6VFAyRTJwTzRWOTY2OUVBSmg3N01EV0Y2eUQxWFI3WmR2VWNUUzJJMVFGRktlZ1pUbS16Nk5JbWJRQWU3UExTTTliOUhXU01xN2pOREhOTDTSAWBBVV95cUxOSUtGRlZJTWRmXzctaEUyZG1CYlMxTTBSell2NnFyS2pzNzhNelQzbVRUMndfQ1RGdmRBSzRrenlJcjRkaWRPT1dPY0F5WmhIMFRweTB3NXFGZWRQSDBYVGo?oc=5" target="_blank"&gt;공급 부족 바이오의약품, 신속 심사로 빠르게 제공한다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;연합뉴스&lt;/font&gt;</description><source url="https://www.yna.co.kr">연합뉴스</source></item><item><title>바이오시밀러 인센티브 검토…업계 "처방 유인 다변화해야" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE16ZEx6TUZCY21kRFJ0Mlg1cVNydUZ6MHZ2OVprc0gzZjJDcHp6WnIxcHlXNFBYTHZyWFI5UTFpb0ZCTUZXYnZ3QWdXRkhXV2RHYmNhdFJidk50UGM4OEtQLWxwbFV2Nmx6b1FN?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE16ZEx6TUZCY21kRFJ0Mlg1cVNydUZ6MHZ2OVprc0gzZjJDcHp6WnIxcHlXNFBYTHZyWFI5UTFpb0ZCTUZXYnZ3QWdXRkhXV2RHYmNhdFJidk50UGM4OEtQLWxwbFV2Nmx6b1FN</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE16ZEx6TUZCY21kRFJ0Mlg1cVNydUZ6MHZ2OVprc0gzZjJDcHp6WnIxcHlXNFBYTHZyWFI5UTFpb0ZCTUZXYnZ3QWdXRkhXV2RHYmNhdFJidk50UGM4OEtQLWxwbFV2Nmx6b1FN?oc=5" target="_blank"&gt;바이오시밀러 인센티브 검토…업계 "처방 유인 다변화해야"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>바이오시밀러 임상 3상 요건 완화 가이드라인 발간 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBPeHliN2FWMFg3eW9TY0JVQ2pLNkZ5UWhfcmNLT1JRTFp4VUxHdjUwUEtaYTJPV1dSc1lWZjFfUXVMME9STFJSd3JjajVmdllMSjZlbk8wWFVyNHY5cm9zLWdpUnliQlhnblJB?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBPeHliN2FWMFg3eW9TY0JVQ2pLNkZ5UWhfcmNLT1JRTFp4VUxHdjUwUEtaYTJPV1dSc1lWZjFfUXVMME9STFJSd3JjajVmdllMSjZlbk8wWFVyNHY5cm9zLWdpUnliQlhnblJB</guid><pubDate>Fri, 27 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBPeHliN2FWMFg3eW9TY0JVQ2pLNkZ5UWhfcmNLT1JRTFp4VUxHdjUwUEtaYTJPV1dSc1lWZjFfUXVMME9STFJSd3JjajVmdllMSjZlbk8wWFVyNHY5cm9zLWdpUnliQlhnblJB?oc=5" target="_blank"&gt;바이오시밀러 임상 3상 요건 완화 가이드라인 발간&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>약가인하 직격탄 맞은 제네릭…바이오시밀러는 '세리머니' - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTFBzOElLZC1LdDg0QVpmQjZ4Nmw1VDlCM3E4bHlMX25pMmhvYmdKU1lFbGFjbTJFNHotb2t0TzlkX253bldCemNCaTQtSVA2UXliY1VCYmhn?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTFBzOElLZC1LdDg0QVpmQjZ4Nmw1VDlCM3E4bHlMX25pMmhvYmdKU1lFbGFjbTJFNHotb2t0TzlkX253bldCemNCaTQtSVA2UXliY1VCYmhn</guid><pubDate>Sat, 28 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBzOElLZC1LdDg0QVpmQjZ4Nmw1VDlCM3E4bHlMX25pMmhvYmdKU1lFbGFjbTJFNHotb2t0TzlkX253bldCemNCaTQtSVA2UXliY1VCYmhn?oc=5" target="_blank"&gt;약가인하 직격탄 맞은 제네릭…바이오시밀러는 '세리머니'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>캐나다, 바이오시밀러 임상 3상 면제[제약·바이오 해외토픽] - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBlMnlxSXZkWWpQeXZwa3MwQjBFWG1SZkJDRmkzdElrY3RxeWhZMVR4Q1J5QkgzMUEtdzNHVGxoRjNMQTBQWVpVelhhNXIxY2VzY2gtZ2dHV3FZelJtQUNnTnc0LUpyQ3M4RHlsSmdB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBlMnlxSXZkWWpQeXZwa3MwQjBFWG1SZkJDRmkzdElrY3RxeWhZMVR4Q1J5QkgzMUEtdzNHVGxoRjNMQTBQWVpVelhhNXIxY2VzY2gtZ2dHV3FZelJtQUNnTnc0LUpyQ3M4RHlsSmdB</guid><pubDate>Sat, 30 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBlMnlxSXZkWWpQeXZwa3MwQjBFWG1SZkJDRmkzdElrY3RxeWhZMVR4Q1J5QkgzMUEtdzNHVGxoRjNMQTBQWVpVelhhNXIxY2VzY2gtZ2dHV3FZelJtQUNnTnc0LUpyQ3M4RHlsSmdB?oc=5" target="_blank"&gt;캐나다, 바이오시밀러 임상 3상 면제[제약·바이오 해외토픽]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>바이오시밀러 시장, 전통제약사도 러쉬 - 메디칼업저버</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFAyTThza3BYSHBseldab05UTW5LbTNhVWFuZFpGTFl3ZVlFaWxuclA5dllYTGZ4X0ZKZWNscm9Sd0k4OUl1X2RnM0xBQlNZZFY0ekN3a25KZC1FYkt1MnpqRzBjMjhZMzViak1Z?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFAyTThza3BYSHBseldab05UTW5LbTNhVWFuZFpGTFl3ZVlFaWxuclA5dllYTGZ4X0ZKZWNscm9Sd0k4OUl1X2RnM0xBQlNZZFY0ekN3a25KZC1FYkt1MnpqRzBjMjhZMzViak1Z</guid><pubDate>Fri, 01 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFAyTThza3BYSHBseldab05UTW5LbTNhVWFuZFpGTFl3ZVlFaWxuclA5dllYTGZ4X0ZKZWNscm9Sd0k4OUl1X2RnM0xBQlNZZFY0ekN3a25KZC1FYkt1MnpqRzBjMjhZMzViak1Z?oc=5" target="_blank"&gt;바이오시밀러 시장, 전통제약사도 러쉬&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼업저버&lt;/font&gt;</description><source url="https://www.monews.co.kr">메디칼업저버</source></item><item><title>미국 의약품 관세 초읽기…제네릭 면제·바이오시밀러 미지수 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE9ydk95ZVlZYVUtZnhaNjFYb2ppS29hbFJHenJFTjZNSUw1VWdGdFZISC1EcWVuNXh1NlBXSWVxcVpXUllyalgzSWJtYkFfamRSQnRZYmp5aE1IR0ZyZDF3YzBydU1XLXhrZzFMaU1wNlNGbUE?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE9ydk95ZVlZYVUtZnhaNjFYb2ppS29hbFJHenJFTjZNSUw1VWdGdFZISC1EcWVuNXh1NlBXSWVxcVpXUllyalgzSWJtYkFfamRSQnRZYmp5aE1IR0ZyZDF3YzBydU1XLXhrZzFMaU1wNlNGbUE</guid><pubDate>Fri, 16 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9ydk95ZVlZYVUtZnhaNjFYb2ppS29hbFJHenJFTjZNSUw1VWdGdFZISC1EcWVuNXh1NlBXSWVxcVpXUllyalgzSWJtYkFfamRSQnRZYmp5aE1IR0ZyZDF3YzBydU1XLXhrZzFMaU1wNlNGbUE?oc=5" target="_blank"&gt;미국 의약품 관세 초읽기…제네릭 면제·바이오시밀러 미지수&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>바이오시밀러 임상 3상 필수 아닌 선택…개발 확대 될까 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBYWlBxejJMUG1YQTBJZUQxME9LX0RGOTVTNER5Mm5VbkROWTNpbE81VGg2bnpkVmRFY2xxQVBKNkVOeDAwY3k0Wm1ZX3pTN3h3eTlWM3lkWWNlWTFuLVFpODZlMXM4aXBLUkVFY3NQemlEd1E?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBYWlBxejJMUG1YQTBJZUQxME9LX0RGOTVTNER5Mm5VbkROWTNpbE81VGg2bnpkVmRFY2xxQVBKNkVOeDAwY3k0Wm1ZX3pTN3h3eTlWM3lkWWNlWTFuLVFpODZlMXM4aXBLUkVFY3NQemlEd1E</guid><pubDate>Fri, 27 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBYWlBxejJMUG1YQTBJZUQxME9LX0RGOTVTNER5Mm5VbkROWTNpbE81VGg2bnpkVmRFY2xxQVBKNkVOeDAwY3k0Wm1ZX3pTN3h3eTlWM3lkWWNlWTFuLVFpODZlMXM4aXBLUkVFY3NQemlEd1E?oc=5" target="_blank"&gt;바이오시밀러 임상 3상 필수 아닌 선택…개발 확대 될까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>국내신약, 개량신약, 독자복합제, 바이오시밀러가 '생존의 열쇠' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE0xb0lyU0lpWC1kYTYxdGsxOFktaUM0TFo4cy1mYXFJaUpuejFOM3R4OVdPSE9xTV9NVEFDOG9IVElWSkVfUWxDTG5vN2lGM3NVSnc1YkpOT3hPQnZOTXhSSEdET3YyeHdmVld3?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE0xb0lyU0lpWC1kYTYxdGsxOFktaUM0TFo4cy1mYXFJaUpuejFOM3R4OVdPSE9xTV9NVEFDOG9IVElWSkVfUWxDTG5vN2lGM3NVSnc1YkpOT3hPQnZOTXhSSEdET3YyeHdmVld3</guid><pubDate>Thu, 02 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE0xb0lyU0lpWC1kYTYxdGsxOFktaUM0TFo4cy1mYXFJaUpuejFOM3R4OVdPSE9xTV9NVEFDOG9IVElWSkVfUWxDTG5vN2lGM3NVSnc1YkpOT3hPQnZOTXhSSEdET3YyeHdmVld3?oc=5" target="_blank"&gt;국내신약, 개량신약, 독자복합제, 바이오시밀러가 '생존의 열쇠'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>바이오시밀러 개발 '공백' 심각... 환자 치료 기회 위협 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE11S0ZaZXljSEF6QzF4NzVqbURFVGFqaWx3alFpNlB2cTY4WDhFekZudkY4blh3Q21LazZNb2RzdndRTDBkVE9ZZWNPZmFJX0pvQmdTV1k0YlBmVTJQSXRMSkI4UE83U3VKX0Z6NA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE11S0ZaZXljSEF6QzF4NzVqbURFVGFqaWx3alFpNlB2cTY4WDhFekZudkY4blh3Q21LazZNb2RzdndRTDBkVE9ZZWNPZmFJX0pvQmdTV1k0YlBmVTJQSXRMSkI4UE83U3VKX0Z6NA</guid><pubDate>Mon, 17 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE11S0ZaZXljSEF6QzF4NzVqbURFVGFqaWx3alFpNlB2cTY4WDhFekZudkY4blh3Q21LazZNb2RzdndRTDBkVE9ZZWNPZmFJX0pvQmdTV1k0YlBmVTJQSXRMSkI4UE83U3VKX0Z6NA?oc=5" target="_blank"&gt;바이오시밀러 개발 '공백' 심각... 환자 치료 기회 위협&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>근래 5년, 내수 시장서 2.5배 성장한 '바이오시밀러'... '남은 파이 충분' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9zVGUteUJScmd0dGpDR3JGOTcwaTNpV3VhVlI3ZklMaDdTVU9CcjJCOFpZdURrT2xEZjcxSFFBNUtYSFZyZHdaN3k0bmdQS1JaaDFwTFluVFpUdnFDdGpmUVp0SDJRUnNUX1E0?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9zVGUteUJScmd0dGpDR3JGOTcwaTNpV3VhVlI3ZklMaDdTVU9CcjJCOFpZdURrT2xEZjcxSFFBNUtYSFZyZHdaN3k0bmdQS1JaaDFwTFluVFpUdnFDdGpmUVp0SDJRUnNUX1E0</guid><pubDate>Tue, 10 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9zVGUteUJScmd0dGpDR3JGOTcwaTNpV3VhVlI3ZklMaDdTVU9CcjJCOFpZdURrT2xEZjcxSFFBNUtYSFZyZHdaN3k0bmdQS1JaaDFwTFluVFpUdnFDdGpmUVp0SDJRUnNUX1E0?oc=5" target="_blank"&gt;근래 5년, 내수 시장서 2.5배 성장한 '바이오시밀러'... '남은 파이 충분'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>미국 FDA "'바이오시밀러 개발 간소화 지침' 초안 공개" - 뉴시스</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFBTcnNxcUt4bElyNWxsTmQ5bnNMc3A2cVc0dldlM1JHQmhlSW9nLUxYenJLdEt6TVdDUE42MGZ2VDdQOE1EVl9ob0F1aUlfU2hHXzU1N2dISjNJWDJfWnBCOdIBeEFVX3lxTE12NnBpcWR1MkpuQkphd0VOdS12ZXpEOTlpcGUwQ0V0UFUxSEpkNEU1V1ZCOUM4YlRET3N2THdiQWtnMmpHM0paUkRzRUN1TGJfVnl2Y1RMODBEa1RtZnFHWEtCVEpZVUlVN1lyS2hMa2VXbmRTUjJuaA?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFBTcnNxcUt4bElyNWxsTmQ5bnNMc3A2cVc0dldlM1JHQmhlSW9nLUxYenJLdEt6TVdDUE42MGZ2VDdQOE1EVl9ob0F1aUlfU2hHXzU1N2dISjNJWDJfWnBCOdIBeEFVX3lxTE12NnBpcWR1MkpuQkphd0VOdS12ZXpEOTlpcGUwQ0V0UFUxSEpkNEU1V1ZCOUM4YlRET3N2THdiQWtnMmpHM0paUkRzRUN1TGJfVnl2Y1RMODBEa1RtZnFHWEtCVEpZVUlVN1lyS2hMa2VXbmRTUjJuaA</guid><pubDate>Wed, 11 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBTcnNxcUt4bElyNWxsTmQ5bnNMc3A2cVc0dldlM1JHQmhlSW9nLUxYenJLdEt6TVdDUE42MGZ2VDdQOE1EVl9ob0F1aUlfU2hHXzU1N2dISjNJWDJfWnBCOdIBeEFVX3lxTE12NnBpcWR1MkpuQkphd0VOdS12ZXpEOTlpcGUwQ0V0UFUxSEpkNEU1V1ZCOUM4YlRET3N2THdiQWtnMmpHM0paUkRzRUN1TGJfVnl2Y1RMODBEa1RtZnFHWEtCVEpZVUlVN1lyS2hMa2VXbmRTUjJuaA?oc=5" target="_blank"&gt;미국 FDA "'바이오시밀러 개발 간소화 지침' 초안 공개"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴시스&lt;/font&gt;</description><source url="https://www.newsis.com">뉴시스</source></item><item><title>정부 "바이오시밀러 빠르게 허가하겠다"…신속심사 규정 시행 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE5KdE82MV9HVVhVMVk3S243NDJlUUJOYk9iOTVwZ29fRzNiZjF6S2xHNXN3bGkzdmI4bnpwS1dvVnFFcm5SalRQNU1jZlNlYVpQVVVpR01iNm1EZ9IBVEFVX3lxTE9zR3djNVpVeWRSNGZpYjVSMW05S09rbnNUTWVkVEUtWmNwX0h1TTY4VDZUT0RQc2d0THdfOTVLT2MxQ0pabFJERXdsTmxFeEFqVE1obg?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE5KdE82MV9HVVhVMVk3S243NDJlUUJOYk9iOTVwZ29fRzNiZjF6S2xHNXN3bGkzdmI4bnpwS1dvVnFFcm5SalRQNU1jZlNlYVpQVVVpR01iNm1EZ9IBVEFVX3lxTE9zR3djNVpVeWRSNGZpYjVSMW05S09rbnNUTWVkVEUtWmNwX0h1TTY4VDZUT0RQc2d0THdfOTVLT2MxQ0pabFJERXdsTmxFeEFqVE1obg</guid><pubDate>Mon, 06 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5KdE82MV9HVVhVMVk3S243NDJlUUJOYk9iOTVwZ29fRzNiZjF6S2xHNXN3bGkzdmI4bnpwS1dvVnFFcm5SalRQNU1jZlNlYVpQVVVpR01iNm1EZ9IBVEFVX3lxTE9zR3djNVpVeWRSNGZpYjVSMW05S09rbnNUTWVkVEUtWmNwX0h1TTY4VDZUT0RQc2d0THdfOTVLT2MxQ0pabFJERXdsTmxFeEFqVE1obg?oc=5" target="_blank"&gt;정부 "바이오시밀러 빠르게 허가하겠다"…신속심사 규정 시행&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>가파르게 성장하는 바이오시밀러, 제조, 규제, 임상, 상업적 요소 고려해야 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFA5S1JDck9YSTZTeXpGcXlwVWdJZHIyeng1NDFPTFY3YzIwaXZwX1hUQm5TLUppZDRuMG4zdW1yX1BrVXNJeWR5TXdmbDNuNU5Wd0VVeHJGY3FGa2RTclI5a3VjM1NObFhBemlJSQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFA5S1JDck9YSTZTeXpGcXlwVWdJZHIyeng1NDFPTFY3YzIwaXZwX1hUQm5TLUppZDRuMG4zdW1yX1BrVXNJeWR5TXdmbDNuNU5Wd0VVeHJGY3FGa2RTclI5a3VjM1NObFhBemlJSQ</guid><pubDate>Mon, 17 Mar 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFA5S1JDck9YSTZTeXpGcXlwVWdJZHIyeng1NDFPTFY3YzIwaXZwX1hUQm5TLUppZDRuMG4zdW1yX1BrVXNJeWR5TXdmbDNuNU5Wd0VVeHJGY3FGa2RTclI5a3VjM1NObFhBemlJSQ?oc=5" target="_blank"&gt;가파르게 성장하는 바이오시밀러, 제조, 규제, 임상, 상업적 요소 고려해야&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>테바, ‘성장으로의 전환’ 전략 본격화… 바이오시밀러 3대 핵심 성과 발표 - 금융경제플러스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9EeWRqLV9JdjN1ak0yRGU0a1k0OFhJVTk0ZWVqVnIzM3hkcHg2QThZMEUzUm53VWVJdUpKSFpwNW1Pb08xX0NfSW9ReExOLTMtOEVvNkRkdzJaazB0TkhVSW9wZ2RuRGhzV0pySQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9EeWRqLV9JdjN1ak0yRGU0a1k0OFhJVTk0ZWVqVnIzM3hkcHg2QThZMEUzUm53VWVJdUpKSFpwNW1Pb08xX0NfSW9ReExOLTMtOEVvNkRkdzJaazB0TkhVSW9wZ2RuRGhzV0pySQ</guid><pubDate>Tue, 31 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9EeWRqLV9JdjN1ak0yRGU0a1k0OFhJVTk0ZWVqVnIzM3hkcHg2QThZMEUzUm53VWVJdUpKSFpwNW1Pb08xX0NfSW9ReExOLTMtOEVvNkRkdzJaazB0TkhVSW9wZ2RuRGhzV0pySQ?oc=5" target="_blank"&gt;테바, ‘성장으로의 전환’ 전략 본격화… 바이오시밀러 3대 핵심 성과 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;금융경제플러스&lt;/font&gt;</description><source url="https://www.kndaily.co.kr">금융경제플러스</source></item><item><title>美 FDA, 의약품·생물학적 제제 승인 시 AI 활용 지침 초안 공개 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBVcDZZbkdwVlFUS1QzVi1rQUtmUnB5c3JFamxrNUN5NnNxdVFRWXowRkdPTE0wMGYzZzNXLUpxTHhXRUZ0OG45V2h2NkVhdW8xNUdXTURLZFhvbzNDbHJfOHVIQjdNMGtud0N1bdIBcEFVX3lxTFBRRlI5eE1tQm8zaDBuczBOa2ZFWk5WN2tHVHVOMTIwSk1NQ29RcEs4U283Y1psWl9CQUtaWWxNOVp2ZlE3WGFZeFplRFhXa0Yyb2l5SF93d2ZXRnFYVlJYRUo0UXNRQlhzSE14TkY3cFA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBVcDZZbkdwVlFUS1QzVi1rQUtmUnB5c3JFamxrNUN5NnNxdVFRWXowRkdPTE0wMGYzZzNXLUpxTHhXRUZ0OG45V2h2NkVhdW8xNUdXTURLZFhvbzNDbHJfOHVIQjdNMGtud0N1bdIBcEFVX3lxTFBRRlI5eE1tQm8zaDBuczBOa2ZFWk5WN2tHVHVOMTIwSk1NQ29RcEs4U283Y1psWl9CQUtaWWxNOVp2ZlE3WGFZeFplRFhXa0Yyb2l5SF93d2ZXRnFYVlJYRUo0UXNRQlhzSE14TkY3cFA</guid><pubDate>Tue, 07 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBVcDZZbkdwVlFUS1QzVi1rQUtmUnB5c3JFamxrNUN5NnNxdVFRWXowRkdPTE0wMGYzZzNXLUpxTHhXRUZ0OG45V2h2NkVhdW8xNUdXTURLZFhvbzNDbHJfOHVIQjdNMGtud0N1bdIBcEFVX3lxTFBRRlI5eE1tQm8zaDBuczBOa2ZFWk5WN2tHVHVOMTIwSk1NQ29RcEs4U283Y1psWl9CQUtaWWxNOVp2ZlE3WGFZeFplRFhXa0Yyb2l5SF93d2ZXRnFYVlJYRUo0UXNRQlhzSE14TkY3cFA?oc=5" target="_blank"&gt;美 FDA, 의약품·생물학적 제제 승인 시 AI 활용 지침 초안 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>바이오시밀러 제일 먼저 낸 삼성바이오에피스 '약가 알박기' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBhbGRzWl9SMFFXX2V6c0hmVzBjZ0dWdFNLblZVSVVXV0p3b0M5TjhVSXRmSEpVQ0Y4RFIwZmxqNHJ2TmFMZUQ0NTdwMms0dUxFekdmemszbWhxNHIxallhUy02dzltRmNaRm53?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBhbGRzWl9SMFFXX2V6c0hmVzBjZ0dWdFNLblZVSVVXV0p3b0M5TjhVSXRmSEpVQ0Y4RFIwZmxqNHJ2TmFMZUQ0NTdwMms0dUxFekdmemszbWhxNHIxallhUy02dzltRmNaRm53</guid><pubDate>Tue, 30 Jul 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBhbGRzWl9SMFFXX2V6c0hmVzBjZ0dWdFNLblZVSVVXV0p3b0M5TjhVSXRmSEpVQ0Y4RFIwZmxqNHJ2TmFMZUQ0NTdwMms0dUxFekdmemszbWhxNHIxallhUy02dzltRmNaRm53?oc=5" target="_blank"&gt;바이오시밀러 제일 먼저 낸 삼성바이오에피스 '약가 알박기'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>셀트리온과 삼성바이오에피스, 8대 바이오 시밀러 기업... 그런데 몇 위? - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5tUWdoM1J0eGxheTdJd05jX1R3bVBvTXdMajhzNjZrRENPMUxzMk11TXI2RC1uZFFnU0ttSFpaR2lkNzNibmVZSWw0V0VNOWh3QlBtSFlaMWRMeTZpVVdEakFRdkd2MVAwaU1n?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5tUWdoM1J0eGxheTdJd05jX1R3bVBvTXdMajhzNjZrRENPMUxzMk11TXI2RC1uZFFnU0ttSFpaR2lkNzNibmVZSWw0V0VNOWh3QlBtSFlaMWRMeTZpVVdEakFRdkd2MVAwaU1n</guid><pubDate>Wed, 21 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5tUWdoM1J0eGxheTdJd05jX1R3bVBvTXdMajhzNjZrRENPMUxzMk11TXI2RC1uZFFnU0ttSFpaR2lkNzNibmVZSWw0V0VNOWh3QlBtSFlaMWRMeTZpVVdEakFRdkd2MVAwaU1n?oc=5" target="_blank"&gt;셀트리온과 삼성바이오에피스, 8대 바이오 시밀러 기업... 그런데 몇 위?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>유럽 바이오시밀러 공백 79%…207조원 '잠재 손실' - 전자신문</title><link>https://news.google.com/rss/articles/CBMiTkFVX3lxTFBUa2M3bWljYk1FQUhkZ3V3RU02ckMyNzM4SDd6NllFcjlVdF9UYm9mYTFybi1MMzg3TmIzdUhqN1F1ZzlEV19lMzNsQk5KUQ?oc=5</link><guid isPermaLink="false">CBMiTkFVX3lxTFBUa2M3bWljYk1FQUhkZ3V3RU02ckMyNzM4SDd6NllFcjlVdF9UYm9mYTFybi1MMzg3TmIzdUhqN1F1ZzlEV19lMzNsQk5KUQ</guid><pubDate>Sun, 22 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTFBUa2M3bWljYk1FQUhkZ3V3RU02ckMyNzM4SDd6NllFcjlVdF9UYm9mYTFybi1MMzg3TmIzdUhqN1F1ZzlEV19lMzNsQk5KUQ?oc=5" target="_blank"&gt;유럽 바이오시밀러 공백 79%…207조원 '잠재 손실'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;전자신문&lt;/font&gt;</description><source url="https://www.etnews.com">전자신문</source></item><item><title>美, 바이오시밀러 PK시험 간소화… 주도권 잡는 K바이오 - 머니투데이 - 머니투데이</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE05dXdEVUNUYjhXaTZyc2ZrcUl4OHdvOUVpSFMwcGIyZm5ZbFNXZWUyUWVadHNHSVQ1U3IycGthcGpQdjJ1b1BGaUFkYUFHTm5fbGQtaks0UXNwS2liVy0tdU1CQ3l1bWI1ZHfSAW9BVV95cUxNc0Q5cFppYWdCZ2FRbGNjYnNiTFlhZEwtanFrMzZseloxM1ZFSy1oZWtwTnJaejVrRms1aFlvOTNITGtjREMybXl2THhQUVBMc1l4VXdLWlh6bHRrMmlZM1ZHQTE0bUVYeFpyeEZ1UVk?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE05dXdEVUNUYjhXaTZyc2ZrcUl4OHdvOUVpSFMwcGIyZm5ZbFNXZWUyUWVadHNHSVQ1U3IycGthcGpQdjJ1b1BGaUFkYUFHTm5fbGQtaks0UXNwS2liVy0tdU1CQ3l1bWI1ZHfSAW9BVV95cUxNc0Q5cFppYWdCZ2FRbGNjYnNiTFlhZEwtanFrMzZseloxM1ZFSy1oZWtwTnJaejVrRms1aFlvOTNITGtjREMybXl2THhQUVBMc1l4VXdLWlh6bHRrMmlZM1ZHQTE0bUVYeFpyeEZ1UVk</guid><pubDate>Wed, 11 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE05dXdEVUNUYjhXaTZyc2ZrcUl4OHdvOUVpSFMwcGIyZm5ZbFNXZWUyUWVadHNHSVQ1U3IycGthcGpQdjJ1b1BGaUFkYUFHTm5fbGQtaks0UXNwS2liVy0tdU1CQ3l1bWI1ZHfSAW9BVV95cUxNc0Q5cFppYWdCZ2FRbGNjYnNiTFlhZEwtanFrMzZseloxM1ZFSy1oZWtwTnJaejVrRms1aFlvOTNITGtjREMybXl2THhQUVBMc1l4VXdLWlh6bHRrMmlZM1ZHQTE0bUVYeFpyeEZ1UVk?oc=5" target="_blank"&gt;美, 바이오시밀러 PK시험 간소화… 주도권 잡는 K바이오 - 머니투데이&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;머니투데이&lt;/font&gt;</description><source url="https://www.mt.co.kr">머니투데이</source></item><item><title>글로벌서 펄펄나는 바이오시밀러, 왜 한국시장에선 힘 못쓰나 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9QNzdFUVV6OE9EMVpyRnFEQ19lSFdOdkt2RE4tM05xcWc1Nkx2SEN3MWp3OU1CVEx4dGZOc3J3X3BfLTBQSFZFaHdvUGdlSWwxem95NXNKdHJUTUJLUGh5UmFreXF6eWptVG1r?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9QNzdFUVV6OE9EMVpyRnFEQ19lSFdOdkt2RE4tM05xcWc1Nkx2SEN3MWp3OU1CVEx4dGZOc3J3X3BfLTBQSFZFaHdvUGdlSWwxem95NXNKdHJUTUJLUGh5UmFreXF6eWptVG1r</guid><pubDate>Wed, 02 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9QNzdFUVV6OE9EMVpyRnFEQ19lSFdOdkt2RE4tM05xcWc1Nkx2SEN3MWp3OU1CVEx4dGZOc3J3X3BfLTBQSFZFaHdvUGdlSWwxem95NXNKdHJUTUJLUGh5UmFreXF6eWptVG1r?oc=5" target="_blank"&gt;글로벌서 펄펄나는 바이오시밀러, 왜 한국시장에선 힘 못쓰나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>美바이오시밀러 허가 간소화…셀트리온·에피스 '자신감' - 뉴시스</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTE95UVF3RW5IYjBnWWFnRC0wcTEyY19adkV0MHd2d1FOeVFIU3dtVnk4Um02MDlvNmNwdjhUTHVwWDkyUGhIV3A1NkZNTmVjOEloMEtwYWg3LVlKcEZLb0syedIBeEFVX3lxTE5PYlRyamJ3cERVZVRvLUNhZ0pKZzA0bkJRNFc4eU5XZERiUktSMS1xR3JJUWJ0clJVLVY1U01vRF9EMzIyQkF6UkZRYk1wdWJ2a2JwdXM3T2FSVHdVay1heXlMS2lyS2JJTThwbUR6SDlRZFd2eFR6OQ?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTE95UVF3RW5IYjBnWWFnRC0wcTEyY19adkV0MHd2d1FOeVFIU3dtVnk4Um02MDlvNmNwdjhUTHVwWDkyUGhIV3A1NkZNTmVjOEloMEtwYWg3LVlKcEZLb0syedIBeEFVX3lxTE5PYlRyamJ3cERVZVRvLUNhZ0pKZzA0bkJRNFc4eU5XZERiUktSMS1xR3JJUWJ0clJVLVY1U01vRF9EMzIyQkF6UkZRYk1wdWJ2a2JwdXM3T2FSVHdVay1heXlMS2lyS2JJTThwbUR6SDlRZFd2eFR6OQ</guid><pubDate>Thu, 29 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE95UVF3RW5IYjBnWWFnRC0wcTEyY19adkV0MHd2d1FOeVFIU3dtVnk4Um02MDlvNmNwdjhUTHVwWDkyUGhIV3A1NkZNTmVjOEloMEtwYWg3LVlKcEZLb0syedIBeEFVX3lxTE5PYlRyamJ3cERVZVRvLUNhZ0pKZzA0bkJRNFc4eU5XZERiUktSMS1xR3JJUWJ0clJVLVY1U01vRF9EMzIyQkF6UkZRYk1wdWJ2a2JwdXM3T2FSVHdVay1heXlMS2lyS2JJTThwbUR6SDlRZFd2eFR6OQ?oc=5" target="_blank"&gt;美바이오시밀러 허가 간소화…셀트리온·에피스 '자신감'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴시스&lt;/font&gt;</description><source url="https://www.newsis.com">뉴시스</source></item><item><title>美, 바이오시밀러 개발비 더 낮춘다…'K-시밀러' 상업화 경쟁력 주목 - 머니투데이 - 머니투데이</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE96ci02WlRwMER0aHpNVzJsc0RuV2ZsU1k3U203ZkRZNjBGTkxpcWdfdTdvMEJjdUo4aE5RVnFyOUFCT3FHTFZYeTYzN2hIZS1jYUlpVmluTzd3ZHM0bE5vc2dWdW9kY010T0HSAW9BVV95cUxQQkxobndYWjZueXpTRVlPemYxcFJnTkRzLUd6M1dzejFrNnJsQUIwcWJzdWtKR2dENlVSN1VUWHNvNmx1QjJ5RHZROUp1RC1iTWQ4RmMxclU0X24xWFRFNm9BSWFUWVVUTG1WWjBTYVU?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE96ci02WlRwMER0aHpNVzJsc0RuV2ZsU1k3U203ZkRZNjBGTkxpcWdfdTdvMEJjdUo4aE5RVnFyOUFCT3FHTFZYeTYzN2hIZS1jYUlpVmluTzd3ZHM0bE5vc2dWdW9kY010T0HSAW9BVV95cUxQQkxobndYWjZueXpTRVlPemYxcFJnTkRzLUd6M1dzejFrNnJsQUIwcWJzdWtKR2dENlVSN1VUWHNvNmx1QjJ5RHZROUp1RC1iTWQ4RmMxclU0X24xWFRFNm9BSWFUWVVUTG1WWjBTYVU</guid><pubDate>Tue, 10 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE96ci02WlRwMER0aHpNVzJsc0RuV2ZsU1k3U203ZkRZNjBGTkxpcWdfdTdvMEJjdUo4aE5RVnFyOUFCT3FHTFZYeTYzN2hIZS1jYUlpVmluTzd3ZHM0bE5vc2dWdW9kY010T0HSAW9BVV95cUxQQkxobndYWjZueXpTRVlPemYxcFJnTkRzLUd6M1dzejFrNnJsQUIwcWJzdWtKR2dENlVSN1VUWHNvNmx1QjJ5RHZROUp1RC1iTWQ4RmMxclU0X24xWFRFNm9BSWFUWVVUTG1WWjBTYVU?oc=5" target="_blank"&gt;美, 바이오시밀러 개발비 더 낮춘다…'K-시밀러' 상업화 경쟁력 주목 - 머니투데이&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;머니투데이&lt;/font&gt;</description><source url="https://www.mt.co.kr">머니투데이</source></item><item><title>바이오시밀러 족쇄 美 상호교환성 폐기 눈앞 - 헬스코리아뉴스</title><link>https://news.google.com/rss/articles/CBMiYkFVX3lxTE9pcXlrWE9xNnN4cDZoQTFjTjhXQzdpUndpc180a3hhM09ibkhtSERhUE1QYldENFZ4bXl3dEFBNmtsOHpuQ1pOUG50d3U3aFJyT2J3cVB5NWZlSXM3MHdQcGt3?oc=5</link><guid isPermaLink="false">CBMiYkFVX3lxTE9pcXlrWE9xNnN4cDZoQTFjTjhXQzdpUndpc180a3hhM09ibkhtSERhUE1QYldENFZ4bXl3dEFBNmtsOHpuQ1pOUG50d3U3aFJyT2J3cVB5NWZlSXM3MHdQcGt3</guid><pubDate>Fri, 21 Jun 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE9pcXlrWE9xNnN4cDZoQTFjTjhXQzdpUndpc180a3hhM09ibkhtSERhUE1QYldENFZ4bXl3dEFBNmtsOHpuQ1pOUG50d3U3aFJyT2J3cVB5NWZlSXM3MHdQcGt3?oc=5" target="_blank"&gt;바이오시밀러 족쇄 美 상호교환성 폐기 눈앞&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스코리아뉴스&lt;/font&gt;</description><source url="https://hkn24.com">헬스코리아뉴스</source></item><item><title>美FDA, 바이오시밀러 승인 절차 대폭 완화…시장 재편 신호탄? - 매경헬스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFA2RmZVUDlvcHhHazIwanVBaGJPT2EwMi12STlVM2gtR1pDanFDLXBUc1NRUVA3M1RlOW1KSFp2QXhhSjV5NU96S2FaMUQ0cXVXUEFZTFBlSFZzUFFrcXpycW43YWs3ZTRnX1YxLQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFA2RmZVUDlvcHhHazIwanVBaGJPT2EwMi12STlVM2gtR1pDanFDLXBUc1NRUVA3M1RlOW1KSFp2QXhhSjV5NU96S2FaMUQ0cXVXUEFZTFBlSFZzUFFrcXpycW43YWs3ZTRnX1YxLQ</guid><pubDate>Mon, 10 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFA2RmZVUDlvcHhHazIwanVBaGJPT2EwMi12STlVM2gtR1pDanFDLXBUc1NRUVA3M1RlOW1KSFp2QXhhSjV5NU96S2FaMUQ0cXVXUEFZTFBlSFZzUFFrcXpycW43YWs3ZTRnX1YxLQ?oc=5" target="_blank"&gt;美FDA, 바이오시밀러 승인 절차 대폭 완화…시장 재편 신호탄?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;매경헬스&lt;/font&gt;</description><source url="https://www.mkhealth.co.kr">매경헬스</source></item><item><title>아달리무맙 바이오시밀러, 건선 치료 효과 오리지널 의약품과 대등 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFA3LWhRTzhEODdjV3NwZmJWbTYySVd1VHJXTkQ0UGoxUDFqZXZvYXhVd28yYS01bkZfOG53MWhpQ3pQN1J0ZERjcFQ5NFJKcGpDcTJpZnB6TU9qNVc4T01HWDJ3X2lCSFV1TEJ0Nw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFA3LWhRTzhEODdjV3NwZmJWbTYySVd1VHJXTkQ0UGoxUDFqZXZvYXhVd28yYS01bkZfOG53MWhpQ3pQN1J0ZERjcFQ5NFJKcGpDcTJpZnB6TU9qNVc4T01HWDJ3X2lCSFV1TEJ0Nw</guid><pubDate>Mon, 10 Mar 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFA3LWhRTzhEODdjV3NwZmJWbTYySVd1VHJXTkQ0UGoxUDFqZXZvYXhVd28yYS01bkZfOG53MWhpQ3pQN1J0ZERjcFQ5NFJKcGpDcTJpZnB6TU9qNVc4T01HWDJ3X2lCSFV1TEJ0Nw?oc=5" target="_blank"&gt;아달리무맙 바이오시밀러, 건선 치료 효과 오리지널 의약품과 대등&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>"제네릭과 바이오시밀러, 특허분쟁 구조 달라… '퍼플북' 다 아냐" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1Mal9ueU1nOXVvWDhwdnhQY3RMRG0zMVhMeGJMOG9NLVRvSDVWZ0UyblVBaU1hS3BNNnBvUzdMb25IUUF4bzgzcl9vWUloQmZlOGxGMzJucTloTjUyQktaaHBMeTdadnNyLU1J?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1Mal9ueU1nOXVvWDhwdnhQY3RMRG0zMVhMeGJMOG9NLVRvSDVWZ0UyblVBaU1hS3BNNnBvUzdMb25IUUF4bzgzcl9vWUloQmZlOGxGMzJucTloTjUyQktaaHBMeTdadnNyLU1J</guid><pubDate>Sat, 02 Dec 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1Mal9ueU1nOXVvWDhwdnhQY3RMRG0zMVhMeGJMOG9NLVRvSDVWZ0UyblVBaU1hS3BNNnBvUzdMb25IUUF4bzgzcl9vWUloQmZlOGxGMzJucTloTjUyQktaaHBMeTdadnNyLU1J?oc=5" target="_blank"&gt;"제네릭과 바이오시밀러, 특허분쟁 구조 달라… '퍼플북' 다 아냐"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>셀트리온·삼성바이오, 시밀러 개발 이유 있었네… 시장 규모 ‘38.5조’ - 헬스조선</title><link>https://news.google.com/rss/articles/CBMidkFVX3lxTE96YXIxdXhOZS1udWxoS015eWh3NUNobTdCWS1oQzN3R0lhSnFudGFFcnRhVy1XN3BIUTN1ZDdBeXpsT3FFMHFJYy1CeXNLUGtxUG8tN2JxdTBlN2V6d3pkRDFrLUx6R0k3THJiLWh3Tjd3Vl9pTmc?oc=5</link><guid isPermaLink="false">CBMidkFVX3lxTE96YXIxdXhOZS1udWxoS015eWh3NUNobTdCWS1oQzN3R0lhSnFudGFFcnRhVy1XN3BIUTN1ZDdBeXpsT3FFMHFJYy1CeXNLUGtxUG8tN2JxdTBlN2V6d3pkRDFrLUx6R0k3THJiLWh3Tjd3Vl9pTmc</guid><pubDate>Sun, 09 Mar 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE96YXIxdXhOZS1udWxoS015eWh3NUNobTdCWS1oQzN3R0lhSnFudGFFcnRhVy1XN3BIUTN1ZDdBeXpsT3FFMHFJYy1CeXNLUGtxUG8tN2JxdTBlN2V6d3pkRDFrLUx6R0k3THJiLWh3Tjd3Vl9pTmc?oc=5" target="_blank"&gt;셀트리온·삼성바이오, 시밀러 개발 이유 있었네… 시장 규모 ‘38.5조’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스조선&lt;/font&gt;</description><source url="https://m.health.chosun.com">헬스조선</source></item><item><title>[이슈] 한국, 2년 연속 FDA 바이오시밀러 최다 승인국 등극 - 한국의약통신</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE50bUE0NnNNN1haZ0hDQlVxNGhNV3ZFWkhxaUNjMlRYUXRwTWRFR21RdEkwT1lIWjYxRHBoU1V2TTdtR25XMk1GUVZKRlA3M2g3emNwaHdKOVRSSHdrd0s4aEZ1M21iVHpseHk0?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE50bUE0NnNNN1haZ0hDQlVxNGhNV3ZFWkhxaUNjMlRYUXRwTWRFR21RdEkwT1lIWjYxRHBoU1V2TTdtR25XMk1GUVZKRlA3M2g3emNwaHdKOVRSSHdrd0s4aEZ1M21iVHpseHk0</guid><pubDate>Tue, 27 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE50bUE0NnNNN1haZ0hDQlVxNGhNV3ZFWkhxaUNjMlRYUXRwTWRFR21RdEkwT1lIWjYxRHBoU1V2TTdtR25XMk1GUVZKRlA3M2g3emNwaHdKOVRSSHdrd0s4aEZ1M21iVHpseHk0?oc=5" target="_blank"&gt;[이슈] 한국, 2년 연속 FDA 바이오시밀러 최다 승인국 등극&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국의약통신&lt;/font&gt;</description><source url="https://www.kmpnews.co.kr">한국의약통신</source></item><item><title>백신·유전자재조합의약품·생물학적제제 간 제조시설 공용 가능 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBmd3B6SHFoenFfNko0RjRnaHdGT01CNGRYRTVvdFJhTGVuaGN5VWdNQ2YwZ20yWXRiVlZvNmFhaHJjYW5YYnRtX3d4bUE1OWx5STdBMmRMZE5OXzRKd0RycmZ6TF9paGl6dkJZcGc2d21qM00?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBmd3B6SHFoenFfNko0RjRnaHdGT01CNGRYRTVvdFJhTGVuaGN5VWdNQ2YwZ20yWXRiVlZvNmFhaHJjYW5YYnRtX3d4bUE1OWx5STdBMmRMZE5OXzRKd0RycmZ6TF9paGl6dkJZcGc2d21qM00</guid><pubDate>Thu, 24 Mar 2022 07:06:25 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBmd3B6SHFoenFfNko0RjRnaHdGT01CNGRYRTVvdFJhTGVuaGN5VWdNQ2YwZ20yWXRiVlZvNmFhaHJjYW5YYnRtX3d4bUE1OWx5STdBMmRMZE5OXzRKd0RycmZ6TF9paGl6dkJZcGc2d21qM00?oc=5" target="_blank"&gt;백신·유전자재조합의약품·생물학적제제 간 제조시설 공용 가능&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>비싸야 팔리는 바이오시밀러의 역설, 그 뒤엔 리베이트가 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5qeFpvTmVMUlYxcEZ6a3BpSm9WQ3VVRGlEMUZWNUpqRW9XbHZIa1BPRl80YlN2cU9QTFltbGJtMlhsM3ktcHhEZDB6Nzhmdk5jOHY1eVFlZ2tvUUJYSE9rVjgzR2s5alMzSWc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5qeFpvTmVMUlYxcEZ6a3BpSm9WQ3VVRGlEMUZWNUpqRW9XbHZIa1BPRl80YlN2cU9QTFltbGJtMlhsM3ktcHhEZDB6Nzhmdk5jOHY1eVFlZ2tvUUJYSE9rVjgzR2s5alMzSWc</guid><pubDate>Thu, 19 Oct 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5qeFpvTmVMUlYxcEZ6a3BpSm9WQ3VVRGlEMUZWNUpqRW9XbHZIa1BPRl80YlN2cU9QTFltbGJtMlhsM3ktcHhEZDB6Nzhmdk5jOHY1eVFlZ2tvUUJYSE9rVjgzR2s5alMzSWc?oc=5" target="_blank"&gt;비싸야 팔리는 바이오시밀러의 역설, 그 뒤엔 리베이트가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>바이오시밀러가 낮춘 약값…건보 재정 3500억 아꼈다 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTFBNWUd1QXB0RHdpT1d5YWdqRzBvakJrdkRUanRTRWhPaEtFU3VZbEhjaXBya0NhTXlfNHVIWmxrVmJadHNNSlVNcHZIeWYydldkNUdKMXQ2SGJyUdIBVEFVX3lxTE5yTWlYM1JONGpXMFo4NV9URTh6VE9lZFRSU1RWdXRUSExyaE9kZWpNQlNGeHNWbXNWNEM4X3dwU2RvVTE0VnphN1VPS1diWTdQdzlTVQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTFBNWUd1QXB0RHdpT1d5YWdqRzBvakJrdkRUanRTRWhPaEtFU3VZbEhjaXBya0NhTXlfNHVIWmxrVmJadHNNSlVNcHZIeWYydldkNUdKMXQ2SGJyUdIBVEFVX3lxTE5yTWlYM1JONGpXMFo4NV9URTh6VE9lZFRSU1RWdXRUSExyaE9kZWpNQlNGeHNWbXNWNEM4X3dwU2RvVTE0VnphN1VPS1diWTdQdzlTVQ</guid><pubDate>Fri, 10 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBNWUd1QXB0RHdpT1d5YWdqRzBvakJrdkRUanRTRWhPaEtFU3VZbEhjaXBya0NhTXlfNHVIWmxrVmJadHNNSlVNcHZIeWYydldkNUdKMXQ2SGJyUdIBVEFVX3lxTE5yTWlYM1JONGpXMFo4NV9URTh6VE9lZFRSU1RWdXRUSExyaE9kZWpNQlNGeHNWbXNWNEM4X3dwU2RvVTE0VnphN1VPS1diWTdQdzlTVQ?oc=5" target="_blank"&gt;바이오시밀러가 낮춘 약값…건보 재정 3500억 아꼈다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>K바이오시밀러…1위 미국과 어깨 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTFBlMmkwbkUwcDJ5cEhtM3pTUFFpOGR4RGVzME1CcGFjZ29nM2lUZE9hTUZ4NXBVWllrdEF5djFhSm5UMENXeFQ4Mm16cXFHVVZCVVdKM2lDOFozd9IBVEFVX3lxTE9Iay1yZzVXdEs3bHFzdlM4el81cVNOTmJaaGZINXNETGlPZE9zc3hLd1A2RkwxaWtMemxJZ0xiakJtdWt5UzdEYXpfZjNNV2xfa2daMQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTFBlMmkwbkUwcDJ5cEhtM3pTUFFpOGR4RGVzME1CcGFjZ29nM2lUZE9hTUZ4NXBVWllrdEF5djFhSm5UMENXeFQ4Mm16cXFHVVZCVVdKM2lDOFozd9IBVEFVX3lxTE9Iay1yZzVXdEs3bHFzdlM4el81cVNOTmJaaGZINXNETGlPZE9zc3hLd1A2RkwxaWtMemxJZ0xiakJtdWt5UzdEYXpfZjNNV2xfa2daMQ</guid><pubDate>Mon, 16 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBlMmkwbkUwcDJ5cEhtM3pTUFFpOGR4RGVzME1CcGFjZ29nM2lUZE9hTUZ4NXBVWllrdEF5djFhSm5UMENXeFQ4Mm16cXFHVVZCVVdKM2lDOFozd9IBVEFVX3lxTE9Iay1yZzVXdEs3bHFzdlM4el81cVNOTmJaaGZINXNETGlPZE9zc3hLd1A2RkwxaWtMemxJZ0xiakJtdWt5UzdEYXpfZjNNV2xfa2daMQ?oc=5" target="_blank"&gt;K바이오시밀러…1위 미국과 어깨&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>너도나도 ‘바이오시밀러’ 만든다지만… 신규 제약사 진입이 어려운 이유 - 헬스조선</title><link>https://news.google.com/rss/articles/CBMidkFVX3lxTFBSWHRMQlJSSk8yVDFHdGNPd2tLcTZCTU04ZnFwRnJWd0dLMzltSGRuLTR4QjV0cExJaDVRUmRJWmtxQktwU25oQmw3a2pJU3lTSzF2ODdVZFFYeGtkR1ZzcFJEQkExemNKRkhmQ2J1d0laTWhIS2c?oc=5</link><guid isPermaLink="false">CBMidkFVX3lxTFBSWHRMQlJSSk8yVDFHdGNPd2tLcTZCTU04ZnFwRnJWd0dLMzltSGRuLTR4QjV0cExJaDVRUmRJWmtxQktwU25oQmw3a2pJU3lTSzF2ODdVZFFYeGtkR1ZzcFJEQkExemNKRkhmQ2J1d0laTWhIS2c</guid><pubDate>Fri, 31 May 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBSWHRMQlJSSk8yVDFHdGNPd2tLcTZCTU04ZnFwRnJWd0dLMzltSGRuLTR4QjV0cExJaDVRUmRJWmtxQktwU25oQmw3a2pJU3lTSzF2ODdVZFFYeGtkR1ZzcFJEQkExemNKRkhmQ2J1d0laTWhIS2c?oc=5" target="_blank"&gt;너도나도 ‘바이오시밀러’ 만든다지만… 신규 제약사 진입이 어려운 이유&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스조선&lt;/font&gt;</description><source url="https://m.health.chosun.com">헬스조선</source></item><item><title>美 FDA, 임상시험 없이 바이오시밀러 허가 추진하나 - IT조선</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTFB1YmVXSWdfS2pRWVdFQ2dMWTlib1JpUFVsbU9mbEpTZlNmUHA1ZFhveDZvVDM1RmdwbUxwSkZ3azg2Z3pHc0ExSVJXd0RtTmxDckN5ZEJYdGV2WU5GSlR1a2piU3NTSXBEbW5aTEx4R1nSAXRBVV95cUxOQnZxcFZKTzJSVl81NEpsbWYtZWNJVVhuS3YwNmYzOUZxRHd5c2w0NW5kZlFYMVA1cVlDRlNOLWduMUVoWnd4WUtEdmRScjc2OE1vbjlibVBEVlJESk80V3BQSkljMzhYa2pVM194cHR4NWlDbw?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTFB1YmVXSWdfS2pRWVdFQ2dMWTlib1JpUFVsbU9mbEpTZlNmUHA1ZFhveDZvVDM1RmdwbUxwSkZ3azg2Z3pHc0ExSVJXd0RtTmxDckN5ZEJYdGV2WU5GSlR1a2piU3NTSXBEbW5aTEx4R1nSAXRBVV95cUxOQnZxcFZKTzJSVl81NEpsbWYtZWNJVVhuS3YwNmYzOUZxRHd5c2w0NW5kZlFYMVA1cVlDRlNOLWduMUVoWnd4WUtEdmRScjc2OE1vbjlibVBEVlJESk80V3BQSkljMzhYa2pVM194cHR4NWlDbw</guid><pubDate>Fri, 31 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTFB1YmVXSWdfS2pRWVdFQ2dMWTlib1JpUFVsbU9mbEpTZlNmUHA1ZFhveDZvVDM1RmdwbUxwSkZ3azg2Z3pHc0ExSVJXd0RtTmxDckN5ZEJYdGV2WU5GSlR1a2piU3NTSXBEbW5aTEx4R1nSAXRBVV95cUxOQnZxcFZKTzJSVl81NEpsbWYtZWNJVVhuS3YwNmYzOUZxRHd5c2w0NW5kZlFYMVA1cVlDRlNOLWduMUVoWnd4WUtEdmRScjc2OE1vbjlibVBEVlJESk80V3BQSkljMzhYa2pVM194cHR4NWlDbw?oc=5" target="_blank"&gt;美 FDA, 임상시험 없이 바이오시밀러 허가 추진하나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;IT조선&lt;/font&gt;</description><source url="https://it.chosun.com">IT조선</source></item><item><title>‘바이오시밀러’ 강국 한국, 성장엔 구조적 한계 분명 … 결국 신약개발이 해답 - 헬스오</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE5WMVdqcDN1TmZxUVR5YzAzUUEwR3VlWGtrT2U4MGdTaVBiOGtPZVFpSzlxWWRrSFRYaWY1M2hhNmtiaElKZndvZHhhRkxWSUl0dzBvTldSUnJEeHBR?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE5WMVdqcDN1TmZxUVR5YzAzUUEwR3VlWGtrT2U4MGdTaVBiOGtPZVFpSzlxWWRrSFRYaWY1M2hhNmtiaElKZndvZHhhRkxWSUl0dzBvTldSUnJEeHBR</guid><pubDate>Fri, 20 Sep 2024 09:18:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5WMVdqcDN1TmZxUVR5YzAzUUEwR3VlWGtrT2U4MGdTaVBiOGtPZVFpSzlxWWRrSFRYaWY1M2hhNmtiaElKZndvZHhhRkxWSUl0dzBvTldSUnJEeHBR?oc=5" target="_blank"&gt;‘바이오시밀러’ 강국 한국, 성장엔 구조적 한계 분명 … 결국 신약개발이 해답&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스오&lt;/font&gt;</description><source url="http://www.healtho.co.kr">헬스오</source></item><item><title>미국 바이오시 밀러 시장 규모, 성장, 공유 | 예측 보고서, 2029 - Fortune Business Insights</title><link>https://news.google.com/rss/articles/CBMikwFBVV95cUxOdnBaQ3VkaTZ1NlFEbWwyWmZsY2pydGlTNFhQSTI1NjNIbkx2SHgzNFhFMUg0cDNBUU1ZX0VRcWFhQ0hMMW14Wk9KN08telpCNGNYYndWX1d4WV9TWTNKa3BlNVpycHN2TUMzM2RUUnVQT3dEbnM3NnY3SjloNkVZM1pxbXhqRzR1MGtXejI3ZWRPRlk?oc=5</link><guid isPermaLink="false">CBMikwFBVV95cUxOdnBaQ3VkaTZ1NlFEbWwyWmZsY2pydGlTNFhQSTI1NjNIbkx2SHgzNFhFMUg0cDNBUU1ZX0VRcWFhQ0hMMW14Wk9KN08telpCNGNYYndWX1d4WV9TWTNKa3BlNVpycHN2TUMzM2RUUnVQT3dEbnM3NnY3SjloNkVZM1pxbXhqRzR1MGtXejI3ZWRPRlk</guid><pubDate>Mon, 08 Jan 2024 12:55:56 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOdnBaQ3VkaTZ1NlFEbWwyWmZsY2pydGlTNFhQSTI1NjNIbkx2SHgzNFhFMUg0cDNBUU1ZX0VRcWFhQ0hMMW14Wk9KN08telpCNGNYYndWX1d4WV9TWTNKa3BlNVpycHN2TUMzM2RUUnVQT3dEbnM3NnY3SjloNkVZM1pxbXhqRzR1MGtXejI3ZWRPRlk?oc=5" target="_blank"&gt;미국 바이오시 밀러 시장 규모, 성장, 공유 | 예측 보고서, 2029&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fortune Business Insights&lt;/font&gt;</description><source url="https://www.fortunebusinessinsights.com">Fortune Business Insights</source></item><item><title>지난해 국내 의약품 시장 역대 최대 규모...바이오시밀러 기여도 ↑ - 메디칼업저버</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFB5dWMwUlptaXQtVFEyWWFibWl2ZmZ5SEFMTFgtUUFLR1NsXzBLZGpud2ZBZkNJN0s2UTM1SEpWb1pocmlZSWF3NHNTckpDY2FlTHA3V0FNRGdHaGtlQkIyLUhnZXZWNzBIUEdv?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFB5dWMwUlptaXQtVFEyWWFibWl2ZmZ5SEFMTFgtUUFLR1NsXzBLZGpud2ZBZkNJN0s2UTM1SEpWb1pocmlZSWF3NHNTckpDY2FlTHA3V0FNRGdHaGtlQkIyLUhnZXZWNzBIUEdv</guid><pubDate>Tue, 08 Aug 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFB5dWMwUlptaXQtVFEyWWFibWl2ZmZ5SEFMTFgtUUFLR1NsXzBLZGpud2ZBZkNJN0s2UTM1SEpWb1pocmlZSWF3NHNTckpDY2FlTHA3V0FNRGdHaGtlQkIyLUhnZXZWNzBIUEdv?oc=5" target="_blank"&gt;지난해 국내 의약품 시장 역대 최대 규모...바이오시밀러 기여도 ↑&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼업저버&lt;/font&gt;</description><source url="https://www.monews.co.kr">메디칼업저버</source></item><item><title>FDA "오리지널에서 바이오시밀러 교체, 안전성 차이 없다" - 메디칼업저버</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBMWXFkU0FVdlNuWjYtVHZtVVhzMHpQYnItOGNVS2lMbXNGQ2JUeS00aldfZ1Jfd1Y5eVphbmM5SHJadk51RDdRS0RMZHVOdWZhUWRvODgxcFNDQll2QnluYUxrWVo0SFRES2Rn?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBMWXFkU0FVdlNuWjYtVHZtVVhzMHpQYnItOGNVS2lMbXNGQ2JUeS00aldfZ1Jfd1Y5eVphbmM5SHJadk51RDdRS0RMZHVOdWZhUWRvODgxcFNDQll2QnluYUxrWVo0SFRES2Rn</guid><pubDate>Tue, 16 Jan 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBMWXFkU0FVdlNuWjYtVHZtVVhzMHpQYnItOGNVS2lMbXNGQ2JUeS00aldfZ1Jfd1Y5eVphbmM5SHJadk51RDdRS0RMZHVOdWZhUWRvODgxcFNDQll2QnluYUxrWVo0SFRES2Rn?oc=5" target="_blank"&gt;FDA "오리지널에서 바이오시밀러 교체, 안전성 차이 없다"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼업저버&lt;/font&gt;</description><source url="https://www.monews.co.kr">메디칼업저버</source></item><item><title>바이오시밀러 시장 점유율 및 규모 | 2030년 글로벌 분석 보고서 - Spherical Insights</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTE5yUi1xdHFMTFVPMUdKb3l4Q0tkb0JXbU8xQl9jUGtWZjltdjItQ29IM08yX3BicHNOOUN3TE85QzF3M3ktcWdLY09jY0I5WkRBeGdjbVZyNkEyYjd3ZHp6eTQ2UFh6MUNocmRUTzEzSm4?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTE5yUi1xdHFMTFVPMUdKb3l4Q0tkb0JXbU8xQl9jUGtWZjltdjItQ29IM08yX3BicHNOOUN3TE85QzF3M3ktcWdLY09jY0I5WkRBeGdjbVZyNkEyYjd3ZHp6eTQ2UFh6MUNocmRUTzEzSm4</guid><pubDate>Tue, 30 Jul 2024 06:55:23 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE5yUi1xdHFMTFVPMUdKb3l4Q0tkb0JXbU8xQl9jUGtWZjltdjItQ29IM08yX3BicHNOOUN3TE85QzF3M3ktcWdLY09jY0I5WkRBeGdjbVZyNkEyYjd3ZHp6eTQ2UFh6MUNocmRUTzEzSm4?oc=5" target="_blank"&gt;바이오시밀러 시장 점유율 및 규모 | 2030년 글로벌 분석 보고서&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Spherical Insights&lt;/font&gt;</description><source url="https://www.sphericalinsights.com">Spherical Insights</source></item><item><title>바이오시밀러 교차처방 허들 낮추는 美 FDA…셀트리온·삼성바이오에피스 '호재' 기대 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE5LZUh3NTJlYWJiTDEweDFicUtDUkxIeWwxWjNYcnN4cGZub3haRDhMbGJjNWJIb0VOemo5V29xSm5CdElLMlhmSUZGYjBXbXJSYTRLWVlwNHNlQdIBVEFVX3lxTE1oTVRGeDRFQXlpQWlJVFFyOUszajdHa1g1d1lXYk85d2RFZi1MU3RTNGhvZlVOX095a1FKNU01dXRQWVZwc3YxVTZrcmoteFVsdGRuTQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE5LZUh3NTJlYWJiTDEweDFicUtDUkxIeWwxWjNYcnN4cGZub3haRDhMbGJjNWJIb0VOemo5V29xSm5CdElLMlhmSUZGYjBXbXJSYTRLWVlwNHNlQdIBVEFVX3lxTE1oTVRGeDRFQXlpQWlJVFFyOUszajdHa1g1d1lXYk85d2RFZi1MU3RTNGhvZlVOX095a1FKNU01dXRQWVZwc3YxVTZrcmoteFVsdGRuTQ</guid><pubDate>Sat, 22 Jun 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5LZUh3NTJlYWJiTDEweDFicUtDUkxIeWwxWjNYcnN4cGZub3haRDhMbGJjNWJIb0VOemo5V29xSm5CdElLMlhmSUZGYjBXbXJSYTRLWVlwNHNlQdIBVEFVX3lxTE1oTVRGeDRFQXlpQWlJVFFyOUszajdHa1g1d1lXYk85d2RFZi1MU3RTNGhvZlVOX095a1FKNU01dXRQWVZwc3YxVTZrcmoteFVsdGRuTQ?oc=5" target="_blank"&gt;바이오시밀러 교차처방 허들 낮추는 美 FDA…셀트리온·삼성바이오에피스 '호재' 기대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>[바이오시밀러 ①] 신약개발보다 바이오시밀러... 글로벌 블록버스터 ‘경쟁 본격화’ - 바이오타임즈</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1aWmpoOEJpa2JsbThpLUE0Q2RVRS1HWWw2VG43eENucHBIVGlLcmtkV2FCVWVlSjZpeXdZYW9HbC1yWlNuby0xOWZieGlucWpPTlJ4MVR5cElzSEJlbTQ2MnhfVVpINkJpanQw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1aWmpoOEJpa2JsbThpLUE0Q2RVRS1HWWw2VG43eENucHBIVGlLcmtkV2FCVWVlSjZpeXdZYW9HbC1yWlNuby0xOWZieGlucWpPTlJ4MVR5cElzSEJlbTQ2MnhfVVpINkJpanQw</guid><pubDate>Wed, 28 Sep 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1aWmpoOEJpa2JsbThpLUE0Q2RVRS1HWWw2VG43eENucHBIVGlLcmtkV2FCVWVlSjZpeXdZYW9HbC1yWlNuby0xOWZieGlucWpPTlJ4MVR5cElzSEJlbTQ2MnhfVVpINkJpanQw?oc=5" target="_blank"&gt;[바이오시밀러 ①] 신약개발보다 바이오시밀러... 글로벌 블록버스터 ‘경쟁 본격화’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오타임즈&lt;/font&gt;</description><source url="https://www.biotimes.co.kr">바이오타임즈</source></item><item><title>삼성바이오에피스·셀트리온, ‘스텔라라' K-바이오시밀러 승부수...인터체인저블 개정 추진에 기대감 - 바이오타임즈</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5lcHBIWVpidVY2LWUzQWpRaWRqX25CWWY0c3c1YWlSVzZYSmNiQ0gyWFZkbVM3T2ZYbUwzMEdidFhnYkZNd003VFB5VEE5MnpOYkZZOXNzUWFkNmFkZ0dRbEJDcXlJeFpLYzNiZA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5lcHBIWVpidVY2LWUzQWpRaWRqX25CWWY0c3c1YWlSVzZYSmNiQ0gyWFZkbVM3T2ZYbUwzMEdidFhnYkZNd003VFB5VEE5MnpOYkZZOXNzUWFkNmFkZ0dRbEJDcXlJeFpLYzNiZA</guid><pubDate>Thu, 04 Jul 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5lcHBIWVpidVY2LWUzQWpRaWRqX25CWWY0c3c1YWlSVzZYSmNiQ0gyWFZkbVM3T2ZYbUwzMEdidFhnYkZNd003VFB5VEE5MnpOYkZZOXNzUWFkNmFkZ0dRbEJDcXlJeFpLYzNiZA?oc=5" target="_blank"&gt;삼성바이오에피스·셀트리온, ‘스텔라라' K-바이오시밀러 승부수...인터체인저블 개정 추진에 기대감&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오타임즈&lt;/font&gt;</description><source url="https://www.biotimes.co.kr">바이오타임즈</source></item><item><title>40조원 바이오시밀러 시장, 초격차 전략 ‘시동’ - 바이오타임즈</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE90YTkzSHhUeEFSUWF3NFlqMnJMWUZHaTh1THl1QnhmYmxOTDhLVXhOZG1obEZsSGFfcTNSbmsxNHVOeXVCaG5YSWpOcnRPQnJpWEtxTVFrQ2Y3a21RRTBmVjFCeU5fWnhILXhYeg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE90YTkzSHhUeEFSUWF3NFlqMnJMWUZHaTh1THl1QnhmYmxOTDhLVXhOZG1obEZsSGFfcTNSbmsxNHVOeXVCaG5YSWpOcnRPQnJpWEtxTVFrQ2Y3a21RRTBmVjFCeU5fWnhILXhYeg</guid><pubDate>Thu, 11 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE90YTkzSHhUeEFSUWF3NFlqMnJMWUZHaTh1THl1QnhmYmxOTDhLVXhOZG1obEZsSGFfcTNSbmsxNHVOeXVCaG5YSWpOcnRPQnJpWEtxTVFrQ2Y3a21RRTBmVjFCeU5fWnhILXhYeg?oc=5" target="_blank"&gt;40조원 바이오시밀러 시장, 초격차 전략 ‘시동’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오타임즈&lt;/font&gt;</description><source url="https://www.biotimes.co.kr">바이오타임즈</source></item><item><title>의약품유통업체 생물학적제제 배송 준비 ‘바쁘다 바뻐’ - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9DbXNCMjBOVUF5aVBIQ185QWdLbWVmOUYzakx6TEJzd1RTQ0FMekdqaGRtRmVONDNnSlE2QTZZdjlRdl81eTVnZlJjX1E0T0VOamhENTkwenRjaGs3bU5ENWRDNmRlYzgwelE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9DbXNCMjBOVUF5aVBIQ185QWdLbWVmOUYzakx6TEJzd1RTQ0FMekdqaGRtRmVONDNnSlE2QTZZdjlRdl81eTVnZlJjX1E0T0VOamhENTkwenRjaGs3bU5ENWRDNmRlYzgwelE</guid><pubDate>Mon, 13 Sep 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9DbXNCMjBOVUF5aVBIQ185QWdLbWVmOUYzakx6TEJzd1RTQ0FMekdqaGRtRmVONDNnSlE2QTZZdjlRdl81eTVnZlJjX1E0T0VOamhENTkwenRjaGs3bU5ENWRDNmRlYzgwelE?oc=5" target="_blank"&gt;의약품유통업체 생물학적제제 배송 준비 ‘바쁘다 바뻐’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>바이오의약품 시장 연평균 10.1%↑...바이오시밀러 수혜 전망 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxOWjBtd293NUZqZ0ZvMkN0S1AyczZtZTVQSTEwQ01lNWtablZSeUNsTjFGVzctMkY2bzRfZWZWQXg2d1VGd0lWTl9JNHJPZVlYM1ZLSjE4ZFhMNG1uRC0wQWVQTkdOdUxKV3dCMWdyT01wMk4xeU5fMDBWRU9wUnNEVG1Ncw?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxOWjBtd293NUZqZ0ZvMkN0S1AyczZtZTVQSTEwQ01lNWtablZSeUNsTjFGVzctMkY2bzRfZWZWQXg2d1VGd0lWTl9JNHJPZVlYM1ZLSjE4ZFhMNG1uRC0wQWVQTkdOdUxKV3dCMWdyT01wMk4xeU5fMDBWRU9wUnNEVG1Ncw</guid><pubDate>Tue, 21 Sep 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOWjBtd293NUZqZ0ZvMkN0S1AyczZtZTVQSTEwQ01lNWtablZSeUNsTjFGVzctMkY2bzRfZWZWQXg2d1VGd0lWTl9JNHJPZVlYM1ZLSjE4ZFhMNG1uRC0wQWVQTkdOdUxKV3dCMWdyT01wMk4xeU5fMDBWRU9wUnNEVG1Ncw?oc=5" target="_blank"&gt;바이오의약품 시장 연평균 10.1%↑...바이오시밀러 수혜 전망&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>유럽 점령한 K바이오시밀러…시장점유율 50% 돌파 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE1IcUphRjJNUlhyenlfOGcxR3lmN0V1WEFZbFdPV1dtVXpUZjJIYnN4SjVwa3QybHM0SmNXLWgwLXZqemN2TlZWOTNDR0U5MjBPeGdDczR4VlJQd9IBVEFVX3lxTE5CQWVPcHluUThTTldYZUdtNDBDWE9PWmRfSWpPc29WTTJQZHl4QWN6N3lkaXU5R1JtYk1EWFBINlJsRXlIcVhvaTdHdnBlT3piRGI4Mg?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE1IcUphRjJNUlhyenlfOGcxR3lmN0V1WEFZbFdPV1dtVXpUZjJIYnN4SjVwa3QybHM0SmNXLWgwLXZqemN2TlZWOTNDR0U5MjBPeGdDczR4VlJQd9IBVEFVX3lxTE5CQWVPcHluUThTTldYZUdtNDBDWE9PWmRfSWpPc29WTTJQZHl4QWN6N3lkaXU5R1JtYk1EWFBINlJsRXlIcVhvaTdHdnBlT3piRGI4Mg</guid><pubDate>Wed, 01 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE1IcUphRjJNUlhyenlfOGcxR3lmN0V1WEFZbFdPV1dtVXpUZjJIYnN4SjVwa3QybHM0SmNXLWgwLXZqemN2TlZWOTNDR0U5MjBPeGdDczR4VlJQd9IBVEFVX3lxTE5CQWVPcHluUThTTldYZUdtNDBDWE9PWmRfSWpPc29WTTJQZHl4QWN6N3lkaXU5R1JtYk1EWFBINlJsRXlIcVhvaTdHdnBlT3piRGI4Mg?oc=5" target="_blank"&gt;유럽 점령한 K바이오시밀러…시장점유율 50% 돌파&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>美 휴미라 바이오시밀러 전쟁 서막…어떤 제품이 승기 잡을까 - 메디칼업저버</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9ZUS1zZTJ4d21YaDdqdE9VZ2ktTmhhMFdvZ1kyR0Z2LUxlUEYtdFg0MW5tRElNU1JSVldFMVE1WlBKTnpheDQ4VWM0ME9KNWNVMS1hTW1odDgzMVY1UG9zUW1FUEtudy1ub2h3?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9ZUS1zZTJ4d21YaDdqdE9VZ2ktTmhhMFdvZ1kyR0Z2LUxlUEYtdFg0MW5tRElNU1JSVldFMVE1WlBKTnpheDQ4VWM0ME9KNWNVMS1hTW1odDgzMVY1UG9zUW1FUEtudy1ub2h3</guid><pubDate>Thu, 01 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9ZUS1zZTJ4d21YaDdqdE9VZ2ktTmhhMFdvZ1kyR0Z2LUxlUEYtdFg0MW5tRElNU1JSVldFMVE1WlBKTnpheDQ4VWM0ME9KNWNVMS1hTW1odDgzMVY1UG9zUW1FUEtudy1ub2h3?oc=5" target="_blank"&gt;美 휴미라 바이오시밀러 전쟁 서막…어떤 제품이 승기 잡을까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼업저버&lt;/font&gt;</description><source url="https://www.monews.co.kr">메디칼업저버</source></item><item><title>[NEW 블록버스터 ③] ‘줄줄이 특허만료’ 바이오시밀러로 블록버스터 노린다 - 바이오타임즈</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9nN2I2TXdJU3lZdm56d2R0OTZScXplendUTTAtdlkwT1IwRDhRS3c1WUdSZGRVQjFrZEp4SWYxRlZZZ0dXMTVmSnpHaWptbXdldFhEaVpaSG9JclBSWTdwYnFWX1NzeVluS19hVg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9nN2I2TXdJU3lZdm56d2R0OTZScXplendUTTAtdlkwT1IwRDhRS3c1WUdSZGRVQjFrZEp4SWYxRlZZZ0dXMTVmSnpHaWptbXdldFhEaVpaSG9JclBSWTdwYnFWX1NzeVluS19hVg</guid><pubDate>Fri, 23 Feb 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9nN2I2TXdJU3lZdm56d2R0OTZScXplendUTTAtdlkwT1IwRDhRS3c1WUdSZGRVQjFrZEp4SWYxRlZZZ0dXMTVmSnpHaWptbXdldFhEaVpaSG9JclBSWTdwYnFWX1NzeVluS19hVg?oc=5" target="_blank"&gt;[NEW 블록버스터 ③] ‘줄줄이 특허만료’ 바이오시밀러로 블록버스터 노린다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오타임즈&lt;/font&gt;</description><source url="https://www.biotimes.co.kr">바이오타임즈</source></item><item><title>휴미라가 촉발한 美 바이오시밀러 시장 경쟁… 韓 기업 이것 명심해야 - 바이오타임즈</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5BQ3NBbGNrNzlPNUZTNzY4Z0Q5NlF5eFN6Q2JuU2lDMGtNNDY4MS10SmhJWHF2cDJGVmY1M19tdW84WTIyWHVTUG1jeTNOSlhXcEphZXVobGRxYUlVczBRNXhVdzZRZHlPdHdhRw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5BQ3NBbGNrNzlPNUZTNzY4Z0Q5NlF5eFN6Q2JuU2lDMGtNNDY4MS10SmhJWHF2cDJGVmY1M19tdW84WTIyWHVTUG1jeTNOSlhXcEphZXVobGRxYUlVczBRNXhVdzZRZHlPdHdhRw</guid><pubDate>Tue, 26 Sep 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5BQ3NBbGNrNzlPNUZTNzY4Z0Q5NlF5eFN6Q2JuU2lDMGtNNDY4MS10SmhJWHF2cDJGVmY1M19tdW84WTIyWHVTUG1jeTNOSlhXcEphZXVobGRxYUlVczBRNXhVdzZRZHlPdHdhRw?oc=5" target="_blank"&gt;휴미라가 촉발한 美 바이오시밀러 시장 경쟁… 韓 기업 이것 명심해야&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오타임즈&lt;/font&gt;</description><source url="https://www.biotimes.co.kr">바이오타임즈</source></item><item><title>[카드뉴스] 바이오의약품 VS 바이오시밀러, 차이는? - 매경헬스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBSdFVRYVFqMlA1dFg4RjVodi13TGdHaUlsY2RiN0d5VlJncTR6a1NacHNhWnRKbWcyMnJfVGRmbUdjX0l4aDJyak9xcFMxeWU3WTl0WnljY0VoMmdzVFotS0c0MG1TY1FieUtaUw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBSdFVRYVFqMlA1dFg4RjVodi13TGdHaUlsY2RiN0d5VlJncTR6a1NacHNhWnRKbWcyMnJfVGRmbUdjX0l4aDJyak9xcFMxeWU3WTl0WnljY0VoMmdzVFotS0c0MG1TY1FieUtaUw</guid><pubDate>Mon, 31 May 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBSdFVRYVFqMlA1dFg4RjVodi13TGdHaUlsY2RiN0d5VlJncTR6a1NacHNhWnRKbWcyMnJfVGRmbUdjX0l4aDJyak9xcFMxeWU3WTl0WnljY0VoMmdzVFotS0c0MG1TY1FieUtaUw?oc=5" target="_blank"&gt;[카드뉴스] 바이오의약품 VS 바이오시밀러, 차이는?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;매경헬스&lt;/font&gt;</description><source url="https://www.mkhealth.co.kr">매경헬스</source></item><item><title>러시아 베트남에 첨단 생물학적 의약품 생산 기술 이전 - Laodong.vn</title><link>https://news.google.com/rss/articles/CBMiuAFBVV95cUxOUWVlRDhxZnZMWC1zUDVLZVhFaDRFSTB6bDg4Z1lSQVFGZzZEV21mM1FfbUFIekd2QXAxWHhHNmZROFN3VUdYdkRVOTBsOGZvUmpZbzFNbU5BZGxubHlXZFJRTFpGa2VpZlM2WDM3blA3RzV5MF9NZjJ6ZVhxaXZnbUxQTGVvbWowTnRleFFkTlhjYVYyRWZyTk9XYWtsUk5LcWcwSF9oeng0b0RfdWJDZHBobFdzeGxn?oc=5</link><guid isPermaLink="false">CBMiuAFBVV95cUxOUWVlRDhxZnZMWC1zUDVLZVhFaDRFSTB6bDg4Z1lSQVFGZzZEV21mM1FfbUFIekd2QXAxWHhHNmZROFN3VUdYdkRVOTBsOGZvUmpZbzFNbU5BZGxubHlXZFJRTFpGa2VpZlM2WDM3blA3RzV5MF9NZjJ6ZVhxaXZnbUxQTGVvbWowTnRleFFkTlhjYVYyRWZyTk9XYWtsUk5LcWcwSF9oeng0b0RfdWJDZHBobFdzeGxn</guid><pubDate>Mon, 15 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOUWVlRDhxZnZMWC1zUDVLZVhFaDRFSTB6bDg4Z1lSQVFGZzZEV21mM1FfbUFIekd2QXAxWHhHNmZROFN3VUdYdkRVOTBsOGZvUmpZbzFNbU5BZGxubHlXZFJRTFpGa2VpZlM2WDM3blA3RzV5MF9NZjJ6ZVhxaXZnbUxQTGVvbWowTnRleFFkTlhjYVYyRWZyTk9XYWtsUk5LcWcwSF9oeng0b0RfdWJDZHBobFdzeGxn?oc=5" target="_blank"&gt;러시아 베트남에 첨단 생물학적 의약품 생산 기술 이전&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Laodong.vn&lt;/font&gt;</description><source url="https://ko.laodong.vn">Laodong.vn</source></item><item><title>"바이오시밀러가 뭐길래?" - 의협신문</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFBEbmJWRC1mVVhZOGN1RVBSTnlXdjhpQVhhek0zUlpyWHJPR245UmdjSDZKM3lSY1AzTHJLUjR6dkpWQk5jZFdfendEWTU1bkFTa3ZrQU5VQWdBLUN3Ylp0MUFva05QSHlDZTFxQmRXdURGdw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFBEbmJWRC1mVVhZOGN1RVBSTnlXdjhpQVhhek0zUlpyWHJPR245UmdjSDZKM3lSY1AzTHJLUjR6dkpWQk5jZFdfendEWTU1bkFTa3ZrQU5VQWdBLUN3Ylp0MUFva05QSHlDZTFxQmRXdURGdw</guid><pubDate>Wed, 02 Dec 2015 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBEbmJWRC1mVVhZOGN1RVBSTnlXdjhpQVhhek0zUlpyWHJPR245UmdjSDZKM3lSY1AzTHJLUjR6dkpWQk5jZFdfendEWTU1bkFTa3ZrQU5VQWdBLUN3Ylp0MUFva05QSHlDZTFxQmRXdURGdw?oc=5" target="_blank"&gt;"바이오시밀러가 뭐길래?"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의협신문&lt;/font&gt;</description><source url="https://www.doctorsnews.co.kr">의협신문</source></item><item><title>유럽 국가별 바이오시밀러 상호대체가능성 입장은 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE9wcVhfejdFTTY2ckVNNWlTRXh4dW5NS2xWanpvbXNLcDVMXzREbHB1ajJwNGRlMnluYm9vSFFtQ0tOTkFSa0szcjZjWGFLc1g3SlpFc3BTMA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE9wcVhfejdFTTY2ckVNNWlTRXh4dW5NS2xWanpvbXNLcDVMXzREbHB1ajJwNGRlMnluYm9vSFFtQ0tOTkFSa0szcjZjWGFLc1g3SlpFc3BTMA</guid><pubDate>Wed, 16 May 2018 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE9wcVhfejdFTTY2ckVNNWlTRXh4dW5NS2xWanpvbXNLcDVMXzREbHB1ajJwNGRlMnluYm9vSFFtQ0tOTkFSa0szcjZjWGFLc1g3SlpFc3BTMA?oc=5" target="_blank"&gt;유럽 국가별 바이오시밀러 상호대체가능성 입장은&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://www.medigatenews.com">MEDI:GATE NEWS</source></item></channel></rss>